cardiostim 2012 advance program

www.cardiostim.fr 1

CARDIOSTIM 2010

18th World Congressin Cardiac Electrophysiology& C a r d i a c Te c h n i q u e s

June 13 >16 I 2012N i c e • F r A N c e

www.cardiostim.com

Pain

ting

by F

ranç

oise

Per

sil lo

n

Advance programA

dvan

ce prog

ram

in collaboration with

Cardiology_Advance_195X265.indd 1 2/23/12 8:39:18 AM

European Heart Rhythm Association (EHRA) Program

Wednesday June 13 / 00:00 AMCARDIAC STEM CELLS AND GENE THERAPYChair: Cohen I. - Stony Brook, USA

Fast V. - Birmingham, USA

• Making Hearts Regenerate Pedrazzini T. - Lausanne, CHE

• Cardiac Differentiation of Human Keratinocytes Derived from Plucked Hair Follicles Binah O. - Haifa, ISR

• Induced Pluripotent Stem Cells from Patients with Inherited Arrhythmias January C. T. - Madison, USA

• What Are the Clinical Implications? Rosen M. R. - New York, USA

• General Discussion

Wednesday June 13 / 00:00 AMNEW IMAGING TECHNIQUESChair: Kalman J. - Melbourne, AUS

Mazgalev T.N. - Cleveland, USA

• Electrocardiographic Imaging to Understand Arrhythmia Mechanisms Rudy Y. - St. Louis, USA

• Simulations to Predict Sites of VT Ablation Trayanova N. A. - Baltimore, USA

• MRI for Risk Prediction of Arrhythmogenic Areas Halperin H. - Baltimore, USA

• What Are the Clinical Implications? Borggrefe M. - Mannheim, DEU


www.cardiostim.com 3

The platform to consult and free downloadECG and Epidemiology data

http://epdatabank.cardiostim.com

Cardiostim 2012


éditorial

Dear Colleagues, Dear Friends,

Today is already tomorrow!

In 2010, we were announcing revolutions in the Electrophysiology world for the years to come. Advances are now on the way, and their first applications will be discussed during the 2012 edition of Cardiostim!

Routine ablation procedures for VT/VF, especially during electrical storms in patients saved by their ICD, robotic and 3D mapping and navigation for EP and ablation techniques, contact force control, new anticoagulants in AF management, transeptal, pericardial or robotic approaches to the left ventricle for CRT, cardiac simulation for understanding arrhythmia mechanisms and CRT, among many others, are some of the major topics that will be introduced and debated!

New recommendations on palpitation management and CRT implantation and follow-up will be presented. Formerly recognized indications will be revisited, such as vaso-vagal syncope, hypertrophic cardiomyopathy or Brugada syndrome. Lots of debates will be organized as shows and you’ll be able to give your opinion through voting systems in many of the programs settled by the most famous experts.

What is unique in Cardiostim is the atmosphere that brings more and more people to this friendly meeting where attendees can freely express their opinion.That is probably why, despite the international financial crisis, more than a thousand abstracts have been received from all over the world, and especially from countries that were not present until now in our congress, demonstrating the interest of colleagues keen to come to Nice to present their data and debate! Congratulations to all authors for their scientific contribution.

The EHRA Program Committee members, conducted by Andreas Goette (Leipzig – Germany), participated actively in the abstract selection in addition to the Cardiostim members. Consequently, each abstract has been reviewed by at least 6 experts. The Selection Committee rejected 43 % abstracts overall. This year, a smaller number of oral abstract sessions is proposed to enhance the quality of the presented material. I must congratulate and thank everyone for these difficult tasks!

As can be seen along this Advance Program, the global result of the combination of EHRA sessions with the traditional programs proposed by our American friends and the Cardiostim Team is a high standard program that one will remind as the most complete and attractive ever!

Our task is to translate this knowledge into understandable and useful information for clinical practice. This is why Cardiostim also proposes educational sessions based on case presentations in the general program as well as dedicated sessions.

With the same logics, specific sessions will be dedicated to technicians and nurses.

Next June, you will enjoy Cardiostim!

Philippe Ritter - Chairman

A messagefrom the Chairman of Cardiostim

springermedizin.de

Up-to-date – Qualifi ed – Online

050357

Clinical Research in Cardiology• Current and competent survey on the diagnosis and therapy of heart and vascular diseases

• Impact Factor 2010: 3.466, rank 31/114 (Journal Citation Reports ® Thomson Reuters)

• Offi cial Journal of the German Cardiac Society

www.crc.springer.de

Extensive online

archive!

Cardiostim 2012

Congress Highlights in 2012




THE EHRA PROGRAMAn extensive program was designed by the Scientific Program Committee of EHRA, and will include a total number of 30 sessions.

HIGH-TECH ADVANCESAmong many others, four sessions will focus on new technologies that will impact our practice in the future with the following topics: understanding of arrhythmia mechanisms and signal processing, computer simulation in electrophysiology and CRT.

HIGH STANDARD EDUCATIONEducational material is proposed in all programs, based on Case presentations. In the EP and ablation section, a specific program is proposed by George Klein on Saturday June 16.

In addition a Program is given in French on devices, and two sessions are dedicated to technicians and nurses.

EPDatabank by cardiostim New in Cardiostim! Educational material is available on http://epdatabank.cardiostim.com for your own purposes. Epidemiologic information, ECG tracings, EGMs, etc… can be downloaded for free!Don’t hesitate to submit yours!

springermedizin.de

Up-to-date – Qualifi ed – Online

050357

Clinical Research in Cardiology• Current and competent survey on the diagnosis and therapy of heart and vascular diseases

• Impact Factor 2010: 3.466, rank 31/114 (Journal Citation Reports ® Thomson Reuters)

• Offi cial Journal of the German Cardiac Society

www.crc.springer.de

Extensive online

archive!

Cardiostim 2012

6

Advance program

Scientific Organizing Committee

CARDIOSTIM TEAMPhilippe Ritter (Bordeaux, FRA)

Pierre Bordachar, Stéphane Garrigue, Sylvain Reuter, Frédéric Sacher (Bordeaux, FRA), Mark O’Neill (London, GBR), Vincent Probst (Nantes, FRA)

David Hayes (Rochester, USA) J.Claude Daubert (Rennes, FRA)

Douglas Zipes (Indianapolis, USA) J.Jacques Blanc (Brest, FRA)

European Heart Rhythm Association (EHRA)President: Angelo Auricchio (Lugano, CHE)Europace 2013 Program Committee Chairman: Andreas Götte (Magdeburg, DEU)Vice-Chairman: John M. Morgan (Southampton, GBR)

Preparation Committee for Scientific ProgramsTo date, will be implemented as we go along

www.cardiostim.com

Abi-Samra F. M. USAAdragao P. PRT Aliot E. FRAAllessie M. NLDAlonso C. FRAAmman P CHEAntzelevitch C. USAArnar D ICEAsirvatham S. J. USAAtie J. BRAAtienza F. ESPAuricchio A. CHEBadhwar N. USABehrenbeck T. USABelott P. H. USABenditt D. G. USABerenfeld O. USABiffi M. ITABinner L. DEUBlanc J. J. FRABlomström-Lundqvist C. SWEBoersma L. NLDBongiorni M. G. ITABordachar P. FRABorggrefe M. DEUBoriani G. ITABotto G. ITABoveda S. FRABoyden P. A. USABrachmann J DEUBraunschweig F. SWEBreithardt G. DEUBrignole M. ITABrugada P. BELBurri H. CHE

Butter C. DEUCalkins H. USACallans D. USACamm A. J. GBRCannom D. S. USACappato R. ITACapucci A. ITACarlson M. D. USACazeau S. FRACha Y. M. USAChen S. A. TWNCheng J. USAChirife R. ARG Clemmensen P.M. DNKCohen I. USACooke D. USACoronel R. NLDCorrado D. ITACowie M. GBRCrijns H. J. NLDCurnis A. ITADanchin N. FRADarrel F. GBRDaubert J. C. FRADavies W. GBRDavy J. M. FRADe Chillou C. FRADe Roy L. BELDeaton C GBRDefaye P. FRADeharo J. C. FRADella Bella P. ITADelnoy P. P. NLDDickstein K. NORDiener H. C. DEU

Dobrev D. DEUDodinot B. FRADolan B. USADorian P. CANDubner S. ARGDuffy H. USADuytschaever M. BELEfimov I. R. USAEhrlich J. DEUEllenbogen K. USAEl-Sherif N. USAEpstein L. USAErdogan A. DEUErnst S. DEUExner D. CANEzekowitz M. D. USAFast V. USAFedorov V. USAFermont L. FRAFernandez Lozano I. ESPFishman G. I. USAFlammang D. FRAFranz M. USAFriedman P. A. USAFurniss S. GBRGaita F. ITAGammage M. GBRGarrigue S. FRAGeelen P. BELGeller C. DEUGerstenfeld E. USAGilmour R. USAGiudici M. USAGoette A. DEUGold M. USA

Gorenek B. TURGras D. FRAGrunnet M. DNKGuiraudon G. M. CANGuirgis M. FRAGulizia M. ITAHachiya H. JPNHaigney M. USAHaines D. E. USAHaïssaguerre M. FRAHalimi F FRAHammill S. C. USAHasin Y. ISR Hastrup Svendse J DNKHatala R. CZEHayes D. USAHealey J. S. USAHeidbüchel H. BELHelland J. USAHill M. USAHindricks G. DEUHirao K. JPNHo I. USAHocini M. FRAHoffmann E. DEUHohnloser S. DEUHombach V. DEUHornberger L. K. USAHusser D DEUIacopino S. ITAIdeker R. E. USAIshikawa T. JPNIsrael C. W. DEUJackman W. M. USAJahangir A. USA

Cardiostim 2012


Jaïs P. FRAJalife J. USAJanse M. NLDJansens J. L. BELJauvert G. FRAJordaens L. NLDJung W DEUKaab S. DEUKacet S. FRAKalifa J. USAKalman J. M. AUSKautzner J. CZEKay N. USAKeane D. USAKennergren C. SWEKenny R. A. IRLKirchhof P. DEUKleber A. CHEKlein G. J. CANKlein H. DEUKlingenheben T. DEUKlug D. FRAKnecht S. BELKnight B. USAKottkamp H. DEUKrieger D. DNKKrueger M. DEUKuck K. H. DEUKusumoto F. USALa Rovere M. T. ITALakatta E. USALau C. P. CHNLazarus A. FRALazzara R. USALe Heuzey J. Y. FRALeclercq C. FRALeclercq J-F FRALee H. C. USALeenhardt A. FRALévy S. FRALewalter T. DEULickfett L. DEULinde C. M. SWELinker N. J. GBRLip GYH GBRLocati E. ITALoh P. NDLLondon B. USALove C. J. USALubinski A. POLMabo P. FRAMaier L. DEUMalik M. GBRManolis A. S. GRCMansour M. USAMantovan R. ITAMarcus F. USAMarkijarvi M. FINMaron B. USAMarrouche N. F. USAMartinek M. AUTMazgalev T. N. USAMcCarty J. USAMcElderry T. USA

McGann C. USAMcKenna W. J. GBRMcVenes R. USAMeine M. NLDMeinertz T. DEUMohr F. W. DEUMolina L. MEXMont L. ESPMoorman A. NLDMorgan J. M. GBRMorillo C. CANMoss A. J. USAMunger T. T. USAMurgatroyd F. D. GBRMyerburg R. J. USANaccarelli G. V. USANademanee K. USANakagawa H. USANakazato Y. JPNNanthakumar K. CANNarayan S. M. USANatale A. USANattel S. CANNerbonne J. USANeumann T. DEUNeuzil P. CZENielsen J. C. DNKNogami A. JPNNorihisa T. JPNOlgin J. USAOlshansky B. USAO’Neill M. GBROpthof T. NLDOseroff O. ARG Oto A. TUROvsyshcher E. ISR Oyarzun R CHLPacker D. L. USAPadeletti L. ITAPage R. L. USAPanfilov A. V. NLDPappone C. ITAParkhomenko A. UKRParry S. W. GBRPedretti R. ITAPelleg A. USAPiccini J. USAPiorkowski C. DEUPoelzing S. DEUPokushalov E RUS Poole J. E. USAPratt C. M. USAPrinzen F. W. NLDPriori S. G. ITAPruvot E. CHEPrystowsky E. N. USAPuererfellner H. AUTQuinn T. GBRRasmussen L. H. DNKRaviele A. ITARea R. USAReddy V. Y. USARevishvilli A. RUSReynolds D. W. USA

Rhode K. GBRRicci R. ITARich M. USARinaldi A. ITARizzo G. ITARoberts P. GBRRoden D. M. USARodriguez E. ESPRoguin A. ISRRohr S. CHERonaszéki A. HUNRosen M. R. USARosenbaum D. S. USARowland E. GBRRozkovec A. DEURudy Y. USARuffy R. USARuiz-Granell R. ESPRuskin J. N. USASacher F. FRASadoul N. FRASaffitz J. E. USASaghy L HUNSaksena S. USASalama G. USASanders P. FRASanguinetti M. USASantini M. ITASantomauro M. ITASavelieva I. GBRSaxon L. USASchaerf R. USASchalij M. NLDScheinman M. USASchilling R. DEUSchleich J. M. FRASchmidt B. DEUSchmidt G. DEUSchotten U. NLDSchuger C. USASchumacher B. DEUSchwartz P. J. ITASchweikert R. USASchwitter J. CHESemisarian C. AUSSermasant M. FRASethi K. INDShah D. CHEShaw R. USAShen W. USAShivkumar K. USAShoda M. JPNSimantirakis E. N. GRCSiu D. CHNSloman G. AUSSmith N. GBRSogaard P. DNKSommer T. DEUSperzel J. DEUSquarcia U. ITASteinbeck G. DEUSteinberg J. USASteinhaus D. USAStern S. ISR

Sternick E. BRAStevenson W. G. USASticherling C. CHEStone P. H. USAStotts L. USASuga C. JPNSulke N. USASutton R. MCOSvendsen J. H. DNKSzili-Török T. NLDTaborsky M. CZETanel R. USAThambo J. B. FRAThermistocles S. ITAThibault B. CANThiene G. ITAThijs V. BELTomaselli G. F. USATondo C. ITATrayanova N. USATreede H. DEUTristani-Firouzi M. USATse H. F. CHNTseng G. N. USATubaro M. ITATuritto G. USAValiunas V. USAvan Gelder I. C. NLDVan Gelder B. NLDVan Wagoner D. R. USAVardas P. E. GRCVarma N. USAVerrier R. L. CANVesin J. M. CHEViskin S. ISRVlietstra R. USAVogt J. DEUVohra J. K. AUSVos M. NLDVrints C. BELWaldo A. L. USAWallentin L. DEUWeiss J. USAWellens H. J. NLDWieling W. NLDWilber D. J. USAWilde A. M. NLDWilkoff B. L. USAWillems S. DEUWolpert C. DEUXhaet O. FRAYamada K. USAYamane T. JPNYang Y. USAYu C. M. CHNZannad F. FRAZareba W. USAZaza A. ITAZeppenfeld K. NLDZieman S. USAZipes D.P. USAZupan I. SVN

Cardiostim 2012

8

Advance program

In collaboration with

www.cardiostim.com

✓ Subscribe to Cardiostim newsletter on www.cardiostim.com

• European Heart Rhythm Association (EHRA)

• Société Française de Cardiologie

• European Society of Cardiology

• Heart Rhythm Society (HRS)

• World Society of Arrhythmias WSA/ICPES

• International Society for Holter and Noninvasive Electrocardiology (ISHNE)

• Groupe Français d’Electrophysiologie et de Stimulation Cardiaque de la Société Française de Cardiologie

• Sociedad Asociación Civil Argentina de Estimulación Cardiaca (SADEC)

• Asian-Pacific Society of Cardiology

• Brazilian Society of Cardiology

• Latin-American Society of Pacing and Electrophysiology (SOLAECE)

• Artificial Cardiac Electrostimulation Department of the Brazilian Cardiac Surgery Group (DECA)

• Associazione Italiana di Aritmologia e Cardiostimolazione (AIAC)

• Mediterranean Society of Pacing and Electrophysiology (MESPE)

• The RETAC Group (Reunion of European countries for the Treatment of Arrhythmias in Cardiology/Réseau Européen pour le Traitement des Arythmies Cardiaques)

CME ACCREDITATION

EHRA SESSIONS at CARDIOSTIM 2012 are currently under review for accreditation by the European Board for Accreditation in Cardiology (EBAC) for external CME credits.

The accreditation results will be announced online and in the final program.

Cardiostim 2012

Contents


European Heart Rhythm Association (EHRA) Program .............................................................................................P. 10

Basic Electrophysiology .............................................................................................................................................P. 19

Complex Electrophysiology and Ablation Techniques ............................................................................................. P. 23

• Novel Approaches to Apply Mechanistic Insights to Complex Human Arrhythmias

Treatments for Atrial Fibrillation ................................................................................................................................P. 29

• Advances and Controversies in Atrial Fibrillation (ACAF)

Noninvasive Electrocardiology ...................................................................................................................................P. 30

• Educational Symposium of International Society for Holter and Noninvasive Electrocardiology (ISHNE)

Main Trials in the Management of Atrial Fibrillation .................................................................................................P. 34

Acute Cardiac Care: Management of SCD .................................................................................................................P. 35

Pacing, ICDs and CRT .................................................................................................................................................P. 36

Leads ...........................................................................................................................................................................P. 43

Associate Symposia ...................................................................................................................................................P. 45

• Cardiostim / HRS Joint Session • Cardiopace • Vaso Vagal Syncope • Geriatric Cardiology • Asia Pacific Cardiostim Symposium • Palpitations • Fetal Cardiology Symposium • Pediatric Cardiac Electrophysiology • Cardiostim-JHRS Joint Session • Syncope • ICE Program • Italian Cardiostim Symposium • EPIC Alliance

Industry Symposia ......................................................................................................................................................P. 53

Symposium STIMUPRAT .............................................................................................................................................P. 59

Cardiostim 2012

The publisher and the Cardiostim organization disclaim any liability for errors or omissions that may come to light, despite the care taken in the production of this Advance Program.

10

Advance program

European Heart Rhythm Association (EHRA) ProgramOrganized by the Scientific Committee of EHRA, Coordination, Program Committee Andreas Götte - Magdeburg, DEU

Wednesday June 13 / 9:00 - 10:30 CRT IN THE 21ST CENTURY. WHAT DO WE HAVE NOW? STATUS QUO AND QUO VADIS?Chair: Boriani G. - Bologna, ITAKuck K. H. - Hamburg, DEU

• CRT in Ischemic Heart Failure Patients: From Cell Function to Clinical Outcome Auricchio A. - Lugano, CHE

• CRT in Patients with Atrial Fibrillation Vardas P. E. - Heraklion, GRC

• Two Years with New Guidelines. Do We Have Unresolved Questions? Dickstein K. - Stavanger, NOR

• CRT in Narrow QRS Ponikowski P. - Wroclaw, POL

Wednesday June 13 / 9:00 - 10:30 PACEMAKER THERAPY IN YEAR 2012Chair: Simantirakis E. N. - Heraklion, GRCOyarzun R. - Santiago, CHL

• How Important Is Minimization of RV Pacing? Israel C. W. - Bielefeld, DEU

• MR Safe Pacemakers Davy J. M. - Montpellier, FRA

• Where in the RV Should Ventricular Pacing Be Applied? Butter C. - Bernau, DEU

• Should AAI Pacing Be Considered Obsolete? Nielsen J. C. - Aarhus, DNK

Wednesday June 13 / 9:00 - 10:30 NEW INSIGHTS IN BASICS OF ARRHYTHMIASChair: Crijns H. J. - Maastricht, NLD Savelieva I. - London, GBR

• Calcium Handling and Arrhythmias: A Link to Be Targeted Zaza A. - Milano, ITA

• «Nodes» in the Arrhythmia Pathogenetic Network Schotten U. - Maastricht, NLD

• Mitochondrial Dysfunction and Arrhythmias O’Rourke B. - Baltimore, USA

• Clinical Evidence and Possible Therapy of These Arrhythmias Van Gelder I. C. - Groningen, NLD

Wednesday June 13 / 9:00 - 10:30 ION CHANNELOPATHIESChair: Jalife J. - Ann Arbor, USAKaab S. - Munchen, DEU

• Long QT Syndrome - Types and Therapies Priori S. G. - Pavia, ITA

• Brugada Syndrome - Place of Ion Channel Antiarrhythmic Drugs Wolpert C. - Mannheim, DEU

• J Wave Syndromes Antzelevitch C. - Utica, USA

• Idiopathic Ventricular Fibrillation - Does It Exist? Wilde A. M. - Amsterdam Zuidoost, NLD

www.cardiostim.com


Wednesday June 13 / 11:00 - 12:30CRT: READING THE GUIDELINESChair: Auricchio A. - Lugano, CHEKirchhof P. - Birmingham, GBR

• CRT in Mild Heart Failure Linde C. M. - Stockholm, SWE

• CRT in Atrial Fibrillation Sutton R. - Monaco, MCO

• CRT in Patients with Conventional Pacemaker Indications Burri H. - Geneva, CHE

• CRT in Clinical Practice: The European CRT Survey Dickstein K. - Stavanger , NOR

Wednesday June 13 / 11:00 - 12:30PURKINJE FIBERS AND VENTRICULAR ARRHYTHMIASChair: Kuck K. H. - Hamburg, DEU Leclercq J. F. - Levallois, FRA

• Arrhythmia of Purkinje Fibers: Specificity of Cellular Mechanisms Ehrlich J. - Frankfurt, DEU

• Effect of Antiarrhythmic Drugs on the Purkinje Network: Electrophysiological and Pharmacological Aspects Vos M. - Utrecht, NLD

• Ablation of Polymorphic VT in Patients with Structural Heart Disease TBD

• Idiopathic VF Originating from the Purkinje Network: Ablation Targets and Long-Term Follow-Up Knecht S. - Brussels, BEL

Wednesday June 13 / 11:00 - 12:30WHAT A DEVICE SPECIALIST NEEDS TO KNOW ABOUT HEART FAILUREChair: Daubert J. C. - Rennes, FRAPonikowski P. - Wroclaw, POL

• Pacing in Heart Failure: What Happens on the Cellular Level? Vanderheyden M. - Aalst, BEL

• Optimal Medical Treatment in Heart Failure Cowie M. - London, GBR

• The Device Patient with End Stage Heart Failure Fruhwald F. - Graz, AUT

• Role of Implantable Sensors in Heart Failure Management Braunschweig F. - Stockholm, SWE


Cardiostim 2012

12

Advance program


www.cardiostim.com

Wednesday June 13 / 14:00 - 15:30NEW EHRA DOCUMENTSChair: Raviele A. - Venice, ITA

• Palpitations Raviele A. - Venice, ITA

• Bleeding Risk Lip G. Y. - Birmingham, GBR

• ‘ICD for Life’ Initiative-Fighting against Sudden Cardiac Death in Emerging Economies. Merkely B. - Budapest, HUN

• Genetic Testing Priori S. G. - Pavia, ITA

Wednesday June 13 / 14:00 - 15:30SUDDEN CARDIAC DEATH IN THE YOUNGChair: Heidbüchel H. - Leuven, BELMorgan J. M. - Southampton, GBR

• Autopsy Rate and Cause of Death in the Young: A National Study from Denmark Winkel B. G. - Copenhagen, DNK

• Brugada Syndrome: Not as Dangerous as First Assumed? Borggrefe M. - Mannheim, DEU

• How Should We Make a Work-Up in Young Cardiac Arrest Survivors? Braunschweig F. - Stockholm, SWE

• Coronary Abnormalities and Sudden Cardiac Death Ho S. Y. - London, GBR

Wednesday June 13 / 16:00 - 17:30ICD THERAPY IN YEAR 2012Chair: Garrigue S. - Bordeaux, FRASvendsen J. H. - Copenhagen, DNK

• Defibrillation Testing during Implant: To Do or Not to Do? Baensch D. - Rostock, DEU

• How to Reduce Inappropriate Shock Therapy Wolpert C. - Mannheim, DEU

• Reliability of Implantable Devices and Leads - Are They Good Enough? Steinhaus D. M. - Mounds View, USA

• How Should We Program Tachy Parameters in ICDs. Zupan I. - Ljubljana, SVN

Wednesday June 13 / 16:00 - 17:30 STATE-OF-THE ART ON VENTRICULAR TACHYCARDIA ABLATIONChair: De Chillou C. - Nancy, FRAWellens H. J. - Maastrisht, NLD

• Endocardial Catheter Ablation of Monomorphic VT: From Bench to EP Lab Atie J. - Rio do Janeiro, BRA

• Epicardial Approach: A First Line Therapy? Della Bella P. - Milano, ITA

• New Mapping and Ablation Strategies for Catheter Ablation of VT in Patients with Dilated Cardiomyopathies Piorkowski C. - Leipzig, DEU

• Combined Ablation Endo-Epicardial Approach for VT Ablation Kottkamp H. - Zurich, CHE


Thursday June 14 / 09:00 - 10:30PREVENTING SUDDEN CARDIAC DEATH WITH RF ABLATIONChair: Haïssaguerre M. - Pessac, FRA Mont L. - Barcelona, ESP

• Mapping and Ablation of Idiopathic Ventricular Fibrillation Sacher F. - Bordeaux, FRA

• Prevention of VF Episodes in Brugada Syndrome by Catheter Ablation Merino J. L. - Madrid, ESP

• Combined Endocardial and Epicardial Ablation in Patients with ARVD Wissner E. - Hamburg, DEU

• Catheter Ablation of Ventricular Electrical Storms Atie J. - Rio do Janeiro, BRA

Thursday June 14 / 09:00 - 10:30STROKE PREVENTION IN ATRIAL FIBRILLATION: STATE-OF-THE ART AND NEW CONCEPTSChair: Camm A. J. - London, GBRRasmussen L. H. - Aalborg, DNK

• Basic Science Insights into the Prothrombotic State in Atrial Fibrillation De Caterina R. - Chieti, ITA

• Clinical Trial Update - What Do the RELY, ROCKET, ARISTOTLE and AVERROES Trials Tell Us? Lip G. Y. - Birmingham, GBR

• Does Aspirin Still Have a Role in Atrial Fibrillation? Grond M. - Berlin, DEU

• What Should the New Guideline Revisions on Stroke Prevention Look Like? Kirchhof P. - Birmingham, GBR

Thursday June 14 / 11:00 - 12:30HIGHLIGHTS FROM EUROPACE 2011: DEVICE THERAPY, INTERVENTIONAL EP AND MEDICAL THERAPYChair: Auricchio A. - Lugano, CHEHindricks G. - Leipzig, DEU

• Interventional EP Merino J. L. - Madrid, ESP

• Pharmacotherapy Camm A. J. - London, GBR

• Pacing Vardas P. E. - Heraklion, GRC

• Defibrillation and CRT-D Wolpert C. - Mannheim, DEU


Cardiostim 2012

14

Advance program


www.cardiostim.com

Thursday June 14 / 14:00 - 15:30CRT IMPLANTATION AND FOLLOW-UP: EHRA-HRS CONSENSUS STATEMENT Chair: Daubert J.C. - Rennes, FRASaxon L. - Los Angeles, USA

• Pre-Implant Evaluation Brignole M. - Lavagna, ITA

• Implantation Singh J. - Boston, USA

• Pre-Discharge Evaluation Leclercq C. - Rennes, FRA

• Device and Heart Failure Follow-Up Israel C.W. - Frankfurt, DEU

• Response to CRT Gold M. - Charleston, USA

• Specific Issues Saxon L. - Los Angeles, USA

Thursday June 14 / 16:00 - 17:30CONTEMPORARY CONSIDERATIONS BASED ON TECHNOLOGICAL DEVELOPMENTS IN CARDIAC PACINGChair: Botto G. - Como, ITA Sutton R. - Monte Carlo, MCO

• Should All Permanent Pacemakers Be MRI Compatible? Santini M. - Roma, ITA

• Is Telemonitoring a New Necessity? Burri H. - Geneva, CHE

• Leadless Pacing: A Step Forward? Roberts P. - Southampton, GBR

• Biological Pacemakers: A Futuristic Approach? Israel C. W. - Bielefeld, DEU

Thursday June 14 / 16:00 - 17:30THE CHALLENGES OF THE ASYMPTOMATIC PATIENT IN HEREDITARY SYNDROMESChair: Priori S. G. - Pavia, ITAWolpert C. - Mannheim, DEU

• Asymptomatic Patient with Long QT Syndrome Schulze-Bahr E. - Munster, DEU

• Asymptomatic Patient with Brugada Syndrome Brugada Terradellas P. - Brussels, BEL

• Asymptomatic Patient with Early Repolarization Syndrome Haïssaguerre M. - Bordeaux, FRA

• Asymptomatic Patient with Catecholaminergic Polymorphic VT Wanguemert Perez F. - Las Palmas, ESP

Thursday June 14 / 16:00 - 17:30TRANSLATIONAL APPROACHES IN ATRIAL FIBRILLATIONChair: Zaza A. - Milano, ITAGoette A. - Magdeburg, DEU

• Genes and Mutations in Patients with Lone Atrial Fibrillation: Do They Matter? Olesen M. - Copenhagen, DNK

• Ionic Remodelling: From Bench to Bedside Van Gelder I. C. - Groningen, NLD

• Structural Remodeling: Which Impact for Catheter Ablation? Schotten U. - Maastricht, NLD

• Atrial and Ventricular Oxidatives Stress during Atrial Fibrillation Lendeckel U. - Greifswald, DEU


Friday June 15 / 09:00 - 10:30IMPROVING OUTCOMES IN THE CATHETER ABLATION OF ATRIAL FIBRILLATIONChair: Kautzner J. - Praha, CZEKuck K. H. - Hamburg, DEU

• Denervation of the Heart. The Role of gP Ablation in Atrial Fibrillation Treatment Pokushalov E. - Novosibirsk, RUS

• Early Ablation of Atrial Fibrillation. Would We Have Better Long-Term Results in the Future? Kirchhof P. - Birmingham, GBR

• Catheter Ablation of the Long-Standing Persistent Atrial Fibrillation. Where We Are Now? Willems S. - Hamburg, DEU

• Current Standard of Care in Atrial Fibrillation Ablation Jaïs P. - Bordeaux, FRA

Friday June 15 / 09:00 - 10:30THE COMPLEX PACEMAKER IMPLANTATIONChair: Davy J. M. - Montpellier, FRA Ponikowski P. - Wroclaw, POL

• Device Implant in Case of Subclavian Vein Occlusion Bracke F. - Eindhoven, NLD

• Implantation of a Pacing System in GUCH Patients Morgan J. M. - Southampton, GBR

• Pacing Considerations in Pediatric Patients Cantu F. - Bergamo, ITA

• Pacemaker Therapy after TAVI Procedure Wissner E. - Hamburg, DEU

Friday June 15 / 11:00 - 12:30COMPLICATIONS RELATED TO ATRIAL FIBRILLATION CATHETER ABLATIONChair: Gaita F. - Asti, ITAHatala R. - Bratislava, SVK

• Prevalence and Predictors of Complications of Radiofrequency Catheter Ablation for Atrial Fibrillation Kautzner J. - Praha, CZE

• Catheter Ablation on Uninterrupted Warfarin: Is It Safe? Schilling R. - London, GBR

• Incidence of Silent Cerebral Thromboembolic Lesions after Atrial Fibrillation Ablation: Predictive Factors? Scaglione M. - Asti, ITA

• Long-Term Rates of Death, Stroke, and Dementia Following Atrial Fibrillation Ablation Day J. - Salt Lake City, USA

Friday June 15 / 11:00 - 12:30CONTINUOUS MONITORING IN ATRIAL FIBRILLATION MANAGEMENT. NEW SCIENCE OR NEW TRUTH?Chair: Lewalter T. - Bonn, DEUZupan I. - Ljubljana, SVN

• Symptomatic/Asymptomatic Events after AF Ablation Hindricks G. - Leipzig, DEU

• Anticoagulation/Antiarrhythmic Management after AF Ablation Kirchhof P. - Birmingham, GBR

• AF Burden in Assessment of Long-Term Success after AF Ablation Puererfellner H. - Linz, AUT

• Management of Early Post-Operative Period. Who Will Need Early Reablation? Pokushalov E. - Novosibirsk, RUS


Cardiostim 2012

16

Advance program


Friday June 15 / 14:00 - 15:30ADVANCES IN ROBOTIC AND 3D MAPPING TECHNOLOGIES FOR ATRIAL FIBRILLATION ABLATIONChair: Kautzner J. - Praha, CZESantini M. - Roma, ITA

• Remote Magnetic Catheter Navigation: Is It the «Gold Standard»? Ernst S. - Hamburg, DEU

• Methods, Efficacy, and Safety of Robotic Catheter Ablation for Atrial Fibrillation Pisapia A. - Marseille, FRA

• Three-Dimensional Rotational Angiography: A New Online Imaging Tool Noelker G. - Bad Oeynhausen, DEU

• Catheter Ablation of Atrial Fibrillation Using a New Non-Fluoroscopic Sensor-Guided 3D Navigation Tool Hindricks G. - Leipzig, DEU

Friday June 15 / 14:00 - 15:30MANAGEMENT OF PATIENTS WITH DEFIBRILLATOR SHOCKS: STATE-OF-THE ARTChair: Boriani G. - Bologna, ITAMorgan J. M. - Southampton, GBR

• Incidence, Predictors and Impact on Mortality van Rees H. - Den Haag, NLD

• ICD Configuration and Programming to Optimise Shock Treatment Katz A. - Ashkelon, ISR

• Results of Catheter Ablation in Patients with Shocks Arenal Maiz A. - Madrid, ESP

• How to Manage Patient Anxiety Ladwig K. H. - München, DEU

Friday June 15 / 16:00 - 17:30DIAGNOSTIC EVALUATION OF SYNCOPE IN SPECIAL PATIENT GROUPSChair: Morgan J. M. - Southampton, GBRTheodorakis G. - Athens, GRC

• Patients with Bundle Branch Block Moya A. - Barcelona, ESP

• Syncope in Athletes Flevari P. - Halandri, GRC

• Syncope in the Elderly: Particularities Kenny R. A. - Dublin, IRL

• Syncope Unit: A New Necessity? Brignole M. - Lavagna, ITA

Friday June 15 / 16:00 - 17:30ARRHYTHMIAS IN WOMEN: STATE OF THE EVIDENCEChair: Borggrefe M. - Mannheim, DEUHeidbüchel H. - Leuven, BEL

• Managing Arrhythmias in Pregnancy: What’s in the Guidelines? Blomstrom-Lundqvist C. - Uppsula, SWE

• Gender Differences in Atrial Fibrillation Mont L. - Barcelona, ESP

• Outcomes in Women Undergoing Electrophysiological Procedures Santangeli P. - Austin, USA

• Implantable Cardioverter Defibrillators in Women Zupan I. - Ljubljana, SVN

www.cardiostim.com


Friday June 15 / 16:00 - 17:30NEW ENERGIES AND TECHNOLOGIES TO TREAT ATRIAL FIBRILLATIONChair: Davies W. - London, GBRKuck K. H. - Hamburg, DEU

• Mapping and Pulmonary Vein Isolation Using the PVAC Duytschaever M. - Brugges, BEL

• Cryoballoon Pulmonary Vein Isolation Guided by Real-Time PV Potential Recording Hoffmann E. - Munich, DEU

• Low-Level Vagosympathetic Nerve Stimulation: A New Target for Atrial Fibrillation Suppression? Jackman W. M. - Oklahoma City, USA

• Minimally Invasive Surgical Techniques: For Which Patients? La Meir M. - Maastricht, NLD

Saturday June 16 / 09:00 - 10:30CERTIFICATION: FIGHTING AGAINST INEQUALITY IN HEALTH CARE ACROSS BORDERSChair: Auricchio A. - Lugano, CHENielsen J. C. - Aarhus, DNK

• A Powerful Tool for Improvement in Health Care Zeppenfeld K. - Leiden, NLD

• Models to Be Listened: UK Linker N. J. - Middlesbrough, GBR

• Certification of Allied Professionals Nolan P. - Galway, IRL

• Certification in Europe: Differences with and Lessons from USA Arribas Ynsaurriaga F. - Madrid, ESP

Saturday June 16 / 09:00 - 10:30 DEBATES AND CONTROVERSIES IN THE ANTITHROMBOTIC MANAGEMENT OF ATRIAL FIBRILLATIONChair: Savelieva I. - London, GBR

• Low Risk Patients with Atrial Fibrillation Can Be Treated with No Antithrombotic Therapy: FOR Fauchier L. - Tours, FRA

• Low Risk Patients with Atrial Fibrillation Can Be Treated with No Antithrombotic Therapy: AGAINST Rasmussen L. H. - Aalborg, DNK

• Antiplatelet Therapy Should Be Added to Anticoagulant Therapy in Patients with Atrial Fibrillation and Vascular Disease: FOR Rubboli A. - Bologna, ITA

• Antiplatelet Therapy Should Be Added to Anticoagulant Therapy in Patients with Atrial Fibrillation and Vascular Disease: AGAINST Marin F. - Murcia, ESP


Cardiostim 2012

18

Advance program


Saturday June 16 / 11:00 - 12:30ANTIARRHYTHMIC DRUGS FOR ATRIAL FIBRILLATIONChair: Capucci A. - Ancona, ITAvan Gelder I. C. - Groningen, NLD

• Basics of Ion Channel Antiarrhythmic Drugs for Prevention of Atrial Fibrillation Dobrev D. - Heidelberg, DEU

• Basics of Upstream Therapies for Prevention of Atrial Fibrillation Goette A. - Magdeburg, DEU

• Ion Channel Antiarrhythmic Drugs for Prevention of Atrial Fibrillation Crijns H. J. - Maastricht, NLD

• Upstream Therapies for Prevention of Atrial Fibrillation Savelieva I. - London, GBR

Saturday June 16 / 11:00 - 12:30 NURSE-LED INTERVENTIONS FOR PATIENTS WITH ARRHYTHMIASChair: Linker N. J. - Middlesbrough, GBRZeppenfeld K. - Leiden, NLD

• COPE-ICD Trial: Comprehensive Rehabilitation for Patients with Implantable Defibrillators Kikkenborg Berg S. - Copenhagen, DNK

• Reducing Psychological Distress for Patients with Implantable Defibrillators Dunbar S. - Atlanta, USA

• Implementing a Nurse-Led Atrial Fibrillation Clinic Hendriks J. M. L. - Maastricht, NLD

• Palpitations: Effectiveness of A Nurse-Led Clinic Smallwood A. - Wolverhampton, GBR

www.cardiostim.com

EHRA Membership 2012, DISCOVER YOUR BENEFITS ON OUR WEB SITE• Special registration fee for EHRA educational courses • Free registration for the EHRA Webinars (e-learning) • 15% discount on EHRA Certification Examinations • 10% off all cardiology publications from Oxford University Press (OUP). • Reduced fee for the EP Europace journal • Exclusive access to EHRA Training Fellowships and a selection of EHRA Educational Content Online • Automatic ESC membership and benefits: Free ESC Pocket Guidelines at the ESC Congress,

Discount prices on the ESC Educational Products, Special subscription prices on ESC Journals (including EHJ), Receive ESC congresses related information, Receive ESC Educational Programme information, A personal European Membership Card (currently for members of some National Cardiac Societies only)

• Receiving the EHRA E-newsletter • Voting rights

More at WWW.ESCARDIO.ORG/EHRA

In parallel with the scientific sessions, EHRA will hold a General Assembly to update members and attendees on its activities, while meetings of various committees and working groups will take place throughout the Congress.


Cardiostim 2012

Basic Electrophysiology Chairman: D. Zipes - Indianapolis, USA

Wednesday June 13 / 09:00 - 10:30CARDIAC STEM CELLS AND GENE THERAPYChair: Cohen I. - Stony Brook, USAFast V. - Birmingham, USA

• Making Hearts Regenerate Pedrazzini T. - Lausanne, CHE

• Cardiac Differentiation of Human Keratinocytes Derived from Plucked Hair Follicles Binah O. - Haifa, ISR

• Induced Pluripotent Stem Cells from Patients with Inherited Arrhythmias January C. T. - Madison, USA

• What Are the Clinical Implications? Rosen M. R. - New York, USA


Wednesday June 13 / 11:00 - 12:30NEW IMAGING TECHNIQUESChair: Kalman J. - Melbourne, AUSMazgalev T.N. - Cleveland, USA

• Electrocardiographic Imaging to Understand Arrhythmia Mechanisms Rudy Y. - St. Louis, USA

• Simulations to Predict Sites of VT Ablation Trayanova N. A. - Baltimore, USA

• MRI for Risk Prediction of Arrhythmogenic Areas Halperin H. - Baltimore, USA

• What Are the Clinical Implications? Borggrefe M. - Mannheim, DEU


Scientific Committee

Ackerman M. - Rochester, USAAnderson M.E. - Iowa City, USAAntzelevitch C. - Utica, USABorggrefe M. - Mannheim, DEUBoyden P. - New York, USAChen P.S. - Indianapolis, USADelmar M. - New York, USAIdeker R. - Birmingham, USA Jalife J. - Ann Arbor, USAKleber A. - Bern, CHELondon B. - Pittsburgh, USAMazgalev T.N. - Cleveland, USAMoss A.J. - Rochester, USA

Nattel S. - Montreal, CAN Priori S. G. - Pavia, ITARoden D.M. - Nashville, USARosen M. R. - New York, USARosenbaum D.S. - Cleveland, USARudy Y. - St Louis, USASaffitz J. - Boston, USASchwartz P. J. - Pavia, ITATomaselli G. - Baltimore, USATrayanova N. A. - Baltimore, USAWeiss J. - Los Angeles, USAWilde A. M. - Amsterdam Zuidoost, NLD

TRANSLATIONAL DISCOVERIES IN CARDIAC ELECTROPHYSIOLOGY: From Cell to Bedside

20

Advance program

Basic Electrophysiology

Wednesday June 13 / 14:00 - 15:30MYOCYTE-FIBROBLAST INTERACTIONS IN NORMAL AND DISEASED MYOCARDIUMChair: Kleber A. - Bern, CHEVos M. - Utrecht, NLD

• Myocyte Fibroblast Interaction Kohl P. - London, GBR

• Myofibroblasts as Arrhythmia Triggers Rohr S. - Bern, CHE

• Electromechanical Consequences of Adult Cardiomyocyte Myofibroblast Interactions Jalife J. - Ann Arbor, USA

• What Are the Clinical Implications? Duffy H. - Boston, USA


Wednesday June 13 / 16:00 - 17:30CARDIAC ION CHANNELS AND MACROMOLECULAR COMPLEXES IN HEALTH AND DISEASEChair: Fishman G. - New York, USAFedorov V. - Columbus, USA

• Macromolecular Complexes and the Control of Cardiac Ion Channel Expression and Distribution Abriel H. - Bern, CHE

• Intercalated Disc as a Macromolecular Complex Niche and Its Role in ARVC Delmar M. - New York, USA

• MAGUK Proteins Are Important in Ion Channel Diseases Hatem S. - Paris, FRA

• What Are the Clinical Implications? Coronel R. - Amsterdam, NLD


Thursday June 14 / 09:00 - 10:30CONTRIBUTION OF GENETICS TO UNDERSTANDING MECHANISMS AND RISKChair: Sanders P. - Adelaide, AUSLazzara R. - Oklahoma City, USA

• Experimental Models to Explain Inherited Diseases Antzelevitch C. - Utica, USA

• Pathology to Explain Phenotype Basso C. - Padova, ITA

• Cellular Electrophysiology to Explain Clinical Phenotypes Napolitano C. - Pavia, ITA

• What Are the Clinical Implications? Moss A. J. - Rochester, USA


Thursday June 14 / 11:00 - 12:30DOES GENETIC TESTING FOR SUDDEN DEATH HELP IN CLINICAL PRACTICE?Chair: Tseng G. N. - Richmond, USAPriori S. G. - Pavia, ITA

• Syndrome Schwartz P. J. - Pavia, ITA

• Brugada Syndrome and CPVT Brugada P. - Aalst, BEL

• Hypertrophic Cardiomyopathy Maron B. - Minneapolis, USA

• Out of Hospital Cardiac Arrest Chugh S. S. - Los Angeles, USA

• What Are the Clinical Implications? Viskin S. - Tel Aviv, ISR

www.cardiostim.com

Cardiostim 2012


Cardiostim 2012


Thursday June 14 / 14:00 - 15:30 THE INTERCALATED DISC AND ARRHYTHMOGENIC CARDIOMYOPATHYChair: Poelzing S. - Salt Lake City, USAEhrlich J. - Frankfurt, DEU

• Based on Science, What Is the Best Name for Arrhythmogenic Right Ventricular Cardiomyopathy? McKenna W. - London, GBR

• Cell-Cell Communication in ARVC Greene K. - Chicago, USA

• Arrhythmia Mechanisms and Therapy Calkins H. - Baltimore, USA

• What Is Needed for a Cure? Thiene G. - Padova, ITA

• What Are the Clinical Implications? Marcus F. - Tucson, USA

Thursday June 14 / 16:00 - 17:30UNDERSTANDING ATRIAL FIBRILLATIONChair: Hocini M. - Bordeaux, FRAProbst V. - Nantes, FRA

• Potassium Channel Remodeling Nattel S. - Montreal, CAN

• Remodeling of Calcium Handling Dobrev D. - Heidelberg, DEU

• Structural Remodeling Allessie M. - Maastricht, NLD

• What Are the Clinical Implications? Natale A. - Austin, USA


Friday June 15 / 09:00 - 10:30ROLE OF CaMKII IN ARRHYTHMIASChair: Maier L. - Goettingen, DEU Gilmour R. - Ithaca, USA

• CaMKII Regulation of Ion Channels Pitt G. - Durham, USA

• CaMKII Regulation of RyR Receptors and Ca Cycling Wehrens X. H. - Houston, USA

• Role of CaMKII in Cardiac Arrhythmias Mohler P. J. - Columbus, USA

• CaMKII as a Potential Antiarrhythmic Target Maier L. - Goettingen, DEU

• What Are the Clinical Implications? Rosenbaum D. S. - Cleveland, USA

Friday June 15 / 11:00 - 12:30ROLE OF THE AUTONOMIC NERVOUS SYSTEM IN ARRHYTHMOGENESISChair: Yamada K. - St. Louis, USA Franz M. - Washington, USA

• Sympathetic-Vagal Interactions in Conscious Dogs Lin S- F. - Indianapolis, USA

• Vagal Modulation of Atrial Arrhythmias Po S. - Oklahoma City, USA

• Vagal Modulation of Inflammation Sabbah H. - Detroit, USA

• What Are the Clinical Implications? Goldberger J. - Chicago, USA

• General discussion

22

Advance program


Friday June 15 / 14:00 - 15:30SMALL CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS (SK) AND CARDIAC ARRHYTHMIASChair: Lakatta E. - Baltimore, USA Opthof T. - Utrecht, NLD

• What Are SK Channels? Chiamvimonvat N. - Chicago, USA

• SK Channels and Ventricular Arrhythmias in Heart Failure Chen P- S. - Indianapolis, USA

• SK Channels Modulate Cardiogenesis Liebau S. - Ulm, DEU

• SK Channels and Genetic Basis of Atrial Fibrillation Ellinor P. - Boston, USA

• What Are the Clinical Implications? Myerburg R. J. - Miami, USA

Friday June 15 / 16:00 - 17:30ROLE OF miRNAs IN ARRHYTHMIA SYNDROMESChair: Grunnet M. - Copenhagen, DNK Boyden P. - New York, USA

• Why All the Interest in miRNAs? Pinto Y. - Amsterdam, NLD

• Hypertrophic Cardiomyopathy Ackerman M. - Rochester, USA

• Long QT Syndrome Wilde A. M. - Amsterdam Zuidoost, NLD

• Dilated Cardiomyopathy Engelhardt S. - Munich, DEU

• What Are the Clinical Implications? Roden D. M. - Nashville, USA

Philippe Coumel SessionIntroduction: from Mechanism to Process. Paradigm Shift?

Wednesday June 13 / 09:00 - 10:30ATRIAL FIBRILLATION: DEALING WITH COMPLEXITYChair: Guiraudon G.M.- London, CAN Klein G. J. - London, CAN

• Intrinsic Autonomic Cardiac Nervous System: New Physiology or Deregulation? Has Neuroablation Predictable Long-Term Effects? Cardinal R. - Montreal, CAN

• Understanding the Complexity of the Substrate of Human AF Allessie M. - Maastricht, NLD

• When Complexity Beats Ablation? Alternative Interventions to Restore Chronotropic Function, and Stroke Prevention Guiraudon G.M. - London, CAN

www.cardiostim.com

Cardiostim 2012


Cardiostim 2012

Complex Electrophysiology and Ablation Techniques Course Directors: Scheinman M. - San Fransciso, USAO’Neill M. - London, GBRProbst V. - Nantes, FRASacher F. - Bordeaux, FRA

Wednesday June 13 / 11:00 - 12:30ATRIAL FIBRILLATION ABLATION I• Mechanisms of Atrial Fibrillation. Implication for Ablation

Strategies Nattel S. - Montreal, CAN

• Real Time Mapping to Guide Atrial Fibrillation Ablation Narayan S. - San Diego, USA

• “MR Imaging:” Does It Have a Role in Atrial Fibrillation Ablation? Marrouche N. F. - Salt Lake City, USA

• Atrial Fibrillation Ablation for Patients with Long Standing Persistent Atrial Fibrillation Sanders P. - Adelaide, AUS

Wednesday June 13 / 14:00 - 15:30ATRIAL FIBRILLATION ABLATION II• Newer Left Atrial Appendage Occlusion and Ligation Devices

for Stroke Prevention: Should They Be Part of an Atrial Fibrillation Procedure? Lee R. J. - San Francisco, USA

• Epicardial Ablation of Atrial Fibrillation Michaud G. F. - Boston, USA

• Catheter Ablation of Atrial Fibrillation Using a Non-Fluoroscopic Sensor Navigation Device Hindricks G. - Leipzig, DEU

• Contact Monitoring and New Ablation Toys Wright M. - London, USA

Wednesday June 13 / 16:00 - 17:30ATRIAL FIBRILLATION ABLATION III• Cryo Balloon Ablation of AF

Ellenbogen K. - Richmond, USA

• Patients Selection for AF Ablation O’Neill M. - London, GBR

• How to Identify Targets and End-Points for Atrial Fibrillation Ablation? Asirvatham S. J. - Rochester, USA

• Long-Term Outcome for Atrial Fibrillation Ablation Knecht S. - Brussels, BEL

24

Advance program

Complex Electrophysiology and Ablation Techniques

Thursday June 14 / 09:00 - 10:30ATRIAL FLUTTER ABLATION• Unusual forms (Double Loop, Lower Loop and Intra-Isthmus

Reentry) Mounsey J. P. - Chapel Hill, USA

• Approach to the Ablation of Post Atrial Fibrillation Induced Left Atrial Flutter Knecht S. - Brussels, BEL

• Diagnoses and Ablation of Right Sided Flutter Yagi T. - Sendai, JPN

Thursday June 14 / 11:00 - 12:30PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA ABLATION I• Mechanisms and Results of Ablative Therapy for Patients with

Focal Junctional Tachycardia Cheng J. - Houston, USA

• Ablation of Complex ANVRT Circuits Badhwar N. - San Francisco, USA

• Diagnoses, Therapy and Results of Ablative Therapy for Patients with Manifest or Concealed Nodo-Fascicular (Ventricular) Pathways Badhwar N. - San Francisco, USA

• Localization and Ablation of Atrial Tachycardias Kalman J. M. - Parkville, AUS

Thursday June 14 / 14:00 - 15:30PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA ABLATION II• Ablation of the Patient with Atrio-Fascicular Pathways

Jackman W. M. - Oklahoma City, USA

• Ablation of Atrial Tachycardia/Accessory Pathways from the Aortic Sinus Kuck K. H. - Hamburg, DEU

• How to Best Diagnose SVT Mechanisms? Callans D. - Philadelphia, USA

• Presentation of Complex Cases (SVT) Scheinman M. - San Fransciso, USA

Thursday June 14 / 16:00 - 17:30INTERACTIVE SESSION• Interactive session

Badhwar N. - San Francisco, USA Kalman J. M. - Parkville, AUS Kuck K. H. - Hamburg, DEU Callans D. - Philadelphia, USA

www.cardiostim.com

Cardiostim 2012


Cardiostim 2012


Friday June 15 / 09:00 - 10:30VENTRICULAR TACHYCARDIA ABLATION I• Role of Identifying and Ablating Late Potentials

Jaïs P. - Bordeaux, FRA

• Recognition and Ablation of Intraseptal VT Bogun F. - Ann Arbor, USA

• Does Cardiac MRI Identify the Critical VT Isthmus? Dickfeld T. - Baltimore, USA

• The Role of Endocardial Unipolar Recordings for VT Ablation Callans D. - Philadelphia, USA

Friday June 15 / 11:00 - 12:30VENTRICULAR TACHYCARDIA ABLATION II• Catheter Ablation of Fascicular Tachycardia in Practice

Nogami A. - Kanagawa, JPN

• Catheter Ablation of VT from Papillary Muscles Kay N. - Birmingham, USA

• VF Ablation in Post MI Patients Snumowski L. - Warsaw, POL

• Long-Term Outcome after VF Ablation Hocini M. - Bordeaux, FRA

Friday June 15 / 14:00 - 15:30VENTRICULAR TACHYCARDIA ABLATION III - Debates• Patients with 1st Appropriate ICD Shock Should be Treated

with Ablation PRO: Sapp J. - Halifax, CAN CON: TBD

• Ablation of AF: First Line Therapy in Electrical Storms PRO: Boyle N. - Los Angeles, USA CON: Coromilas J. - New York, USA

Friday June 15 / 16:00 - 17:30VENTRICULAR TACHYCARDIA ABLATION IV• Catheter Ablation of Patients with Arrhythmogenic Right

Ventricular Dysplasia (ARVD) Reddy V. Y. - Boston, USA

• Catheter Ablation of Patients with VT and Systemic Disease (Sarcoid/Amyloid/Iron Overload/Myotonic Dystrophy) Arruda M. - Case Western, USA

• Ablation of the Patient with Ischemic VT Soejima K. - Kawasaki, JPN

• Bipolar Voltage Map vs. MR for Detection of Myocardial Scar Gerstenfeld E. P. - Philadelphia, USA

26

Advance program


Cases Discussion in ElectrophysiologyOrganized by Klein G.J. - London, CAN Sacher F. - Bordeaux-Pessac, FRA O’Neill M. - London, GBR

Speakers are invited to present 1 or 2 cases they found instructive or challenging. The problem might be diagnostic or related to ablation complexity.

Speakers should be prepared to be interrupted and participate in dialogue during the presentation and consider this in the length of their presentation.

State-of-the-Art in the Brugada SyndromeOrganized by Sacher F. - Bordeaux-Pessac, FRA

Saturday June 16 / 9:00 - 10:30THE CHALLENGING CASE - Part IChair: Klein G. J. - London, CANCallans D. - Philadelphia, USAO’Neill M. - London, GBRSkanes A. - London, CAN

Saturday June 16 / 11:00 - 12:30THE CHALLENGING CASE - Part IIChair:Klein G. J. - London, CANCallans D. - Philadelphia, USAO’Neill M. - London, GBRSkanes A. - London, CAN

Friday June 15 / 09:00 - 10:30THERAPEUTIC OPTIONS IN BRUGADA SYNDROME

• Risk Stratification in Brugada Syndrome Delise P. - Trevise, ITA

• Outcome after ICD Implantation Sacher F. - Bordeaux-Pessac, FRA

• VF Ablation in Brugada Syndrome Nademanee K. - Los Angeles, USA

Friday June 15 / 11:00 - 12:30UNSOLVED ISSUES IN BRUGADA SYNDROMEChair: Wilde A. M. - Amsterdam Zuidoost, NLD Antzelevitch C. - Utica, USA

• SCN5A: Which Role in Brugada Syndrome? Probst V. - Nantes, FRA

• Brugada Syndrome Mechanism: Depolarization/Repolarization or Different Entities with a Same ECG Pattern Postema P.G. - Amsterdam, NLD

• Value of Electrophysiological Study for Risk Stratification: The PRELUDE Study Priori S. G. - Pavia, ITA

www.cardiostim.com


Cardiostim 2012


Novel Approaches to Apply Mechanistic Insights to Complex Human ArrhythmiasOrganized by E. Pruvot - Lausanne, CHE & S. Narayan - San Diego, USA

Goals: To discuss the implementation and practical application of principles and insights from basic science to understand and treat human arrhythmias. Because the detailed mapping and tissue analyses for in silico, in vitro and in vivo animal models often cannot be applied in patients, this session will also discuss technical innovations that have enabled successful translational patient studies.

Thursday June 14 / 14:00 - 15:30MECHANISTIC APPROACHES TO COMPLEX ARRHYTHMIAS - PART I: REPOLARIZATION ALTERNANS – TRANSLATING FUNDAMENTAL OBSERVATIONS TO CLINICAL PRACTICE FOR ATRIAL AND VENTRICULAR ARRHYTHMIASChair: Pruvot E. - Lausanne, CHE Narayan S. - San Diego, USA

• From Pulsus to Pulseless: The Saga of Cardiac Repolarization Alternans Rosenbaum D. S. - Cleveland, USA

• Intermittent Atrial Tachycardia Promotes Repolarization Alternans and Susceptibility to AF in a Free-Behaving Sheep Model Pruvot E. - Lausanne, CHE

• Atrial Repolarization Alternans as a Dynamic Substrate Promoting Wavebreaks in Human Paroxysmal and Persistent AF Narayan S. - San Diego, USA

• SERCA2A Overexpression as a Molecular Intervention to Suppress Repolarization Alternans and Susceptibility of Cardiac Fibrillation Cutler M. - Cleveland, USA

• Intracardiac Repolarization Alternans/Variability Predicts Imminent Ventricular Tachyarrhythmias in ICD Recipients Swerdlow C. D. - Los Angeles, USA

Thursday June 14 / 16:00 - 17:30MECHANISTICALLY-GUIDED THERAPIES FOR HUMAN CARDIAC FIBRILLATION - PART II - ATRIAL ARRHYTHMIASChair: Berenfeld O. - Ann Arbor, USA

• Basic Science of Atrial Fibrillatory Sources: The Role of Rotors vs Multiple Wavelets Jalife J. - Ann Arbor, USA

• Localized Rotors and Focal Beats in Human Atrial Fibrillation Narayan S. - San Diego, USA

• Clinical Application of Noninvasive Electrocardiographic Imaging (ECGI) Cuculich P. - St Louis, USA

• Electrogram Correlates of Localized Sources During AF Mansour M. - Boston, USA

• Role of Imaging and Ablating Structural Obstacles to Treat Human AF Marrouche N. F. - Salt Lake City, USA

28

Advance program


Friday June 15 / 09:00 - 10:30MECHANISTICALLY-GUIDED APPROACHES TO HUMAN CARDIAC FIBRILLATION - PART III - VENTRICULAR ARRHYTHMIASChair: Shivkumar K. - San Diego, USA

• Trigger Mechanisms for Human Ventricular Fibrillation Knecht S. - Bordeaux, FRA

• Recent Developments in Defibrillation and in Understanding Ventricular Fibrillation Ideker R. - Birmingham, USA

• What Is the Optimal Mapping Approach to Guide Ablation of Human Ventricular Tachyarrhythmias? Shivkumar K. - Los Angeles, USA

• Signal Processing Approaches to Guide Complex Ablation in the Atria and Ventricles Chen S.A. - Taipei, TWN

• Signal Processing Insights into the Mechanisms of Human Ventricular Arrhythmias Krummen D.E. - San Diego, USA

Computer ModellingOrganized by Maxime Sermasant - Sophia Antipolis, FRA from INRIA (Institut National de Recherche en Informatique et Automatique)

Thursday June 14 / 11:00 - 12:30COMPUTATIONAL ELECTROPHYSIOLOGY: NOVEL TOOLS TO IMPROVE CLINICAL UNDERSTANDINGChair: Panfilov A. V. - Gent, BELRhode K. - London, GBR

• Electrotonic Modulation of Cardiac Repolarization in Health and Disease: Insights from a Combined Computational and Experimental Study Bernus O. - Bordeaux-Pessac, FRA

• Electro-Mechanical Interaction – Is This Something the Clinical Electrophysiologist Has to Care about or Is This only of Interest to the Cellular Researcher? Bijnens B. - Barcelona, ESP

• Electrical and Structural Characteristics of Border Zone in Infarcted Swine: Insights from 3D MR Image-Based Computer Models, Histopathology and EP Data Pop M. - Toronto, CAN

• Cardiac Radiofrequency Ablation Planning from Personalized Biophysical Models Delingette H. - Sophia-Antipolis, FRA

www.cardiostim.com


Cardiostim 2012

Treatments of Atrial Fibrillation

Advances and Controversies in Atrial Fibrillation (ACAF)Chairman: Naccarelli G. V. - Hershey, USABlanc J.J. - Brest, FRALévy S. - Marseille, FRA

Unrestricted Educational Support: sanofi aventis

Thursday June 14 / 09:00 - 10:30ATRIAL FIBRILLATION IChair: Naccarelli G. V. - Hershey, USABoriani G. - Bologna, ITA

• Early Attempts at Rhythm Control Slows Progression of AF Crijns H. J. - Maastricht, NLD

• Has Basic Science Helped Us Develop Better Pharmacologic and Ablative Therapies for AF? Allessie M. - Maastricht, NLD

• Upstream Therapy of AF – Is It All over but the Shouting? Dorian P. - Toronto, CAN

Thursday June 14 / 11:00 - 12:30ATRIAL FIBRILLATION IIChair: van Gelder I. C. - Groningen, NLDCapucci A. - Ancona, ITA

• Dronedarone in 2012: What is New? Le Heuzey J. Y. - Paris , FRA

• PALLAS: Why Was It Performed? Where Are We? Hohnloser S. - Frankfurt, DEU

• Dronedarone and Ranolazine: Is a Combination Drug a Good Idea ? Antzelevitch C. - Utica, USA

Thursday June 14 / 14:00 - 15:30ATRIAL FIBRILLATION IIIChair: Santini M. - Rome, ITABreithardt G. - Münster, DEU

• Novel Anticoagulants: Where Are We in 2012? Naccarelli G. V. - Hershey, USA

• Can Newer Anticoagulants Be Used Safely for Cardioversion of AF Patients? Aliot E. - Nancy, FRA

• Antiarrhythmic/Anticoagulant Drug Interactions: What Do We Know? Tamargo J. - Madrid, ESP

Thursday June 14 / 16:00 - 17:30ATRIAL FIBRILLATION IVChair: Lévy S. - Marseille, FRAVardas P. E. - Heraklion, GRC

• Asymptomatic AF: Prognostic Implications Blanc J. J. - Brest, FRA

• Is Catheter Ablation of AF Prothrombotic or Antithrombotic? Packer D. L. - Rochester, USA

• Role of Novel Anticoagulants During AF Ablation Procedures? Cappato R. - San Donato Milanese (MI), ITA

30

Advance program

Noninvasive Electrocardiology

International Symposium on High Resolution ECG and Late Potentials, and Noninvasive ElectrophysiologyChairpersons: El-Sherif N. - USATuritto G. - USA

SUDDEN CARDIAC DEATH - FROM MOLECULAR BIOLOGY TO CLINICAL MANAGEMENT: AN UNFINISHED ODYSSEY

Wednesday June 13 / 16:00 - 17:30CASE#1: 65 y/o male, h/o ASWMI; s/p CABGx3, 5 weeks ago; LVEF=38%, presents with a recent syncopal episodeChair: El-Sherif N. - Brooklyn, USA

• Post-MI Remodeling; Molecular and Electrophysiological Substrates El-Sherif N. - Brooklyn, USA

• Are Noninvasive Risk Stratification of Post-MI Patients Still Relevant ? La Rovere M. T. - Pavia, ITA

• How to Risk Stratify SCD in Post-MI Patients with LVEF>35% Turitto G. - Brooklyn, USA

• Panel consensus: How to Best Manage This Patient

Thursday June 14 / 09:00 - 10:30CASE#2: 54 y/o female with no cardiac risk factors presents with CHF, LVEF=25%, and LBBB Chair: Turitto G. - Brooklyn, USA

• Molecular Biology and Pathophysiology of Non-Ischemic Cardiomyopathy Corrado D. - Padova, ITA

• QRS Duration and Configuration. The Need to Modify Selection Criteria for CRT Zareba W. - Rochester, USA

• Does the Controversy of CRT-P vs CRT-D Still Exist? Klein H. - Rochester, USA


www.cardiostim.com


Thursday June 14 / 11:00 - 12:30CASE#3: 29 y/o male collapsed and spontaneously recovered during running NY Marathon, ECG= LVH pattern, 2-D echo= suggestive of hypertrophic cardiomyopathyChair: Lévy S. - Marseille, FRA

• Molecular Biology of Hypertrophic CMP Ackerman M. - Rochester, USA

• Pathophysiology of SCD in Athletes Thiene G. - Padova, ITA

• Risk Stratification of SCD in Athletes Biffi M. - Bologna, ITA


Thursday June 14 / 14:00 - 15:30CASE#4: 45 y/o male presents with one syncopal episode, normal 2-D echo. ECG=prominent early repolarization wave in inferior surface leadsChair: Breithardt G. - Münster, DEU

• Benign vs Malignant Early Repolarization Napolitano C. - Pavia, ITA

• Continuous Spectrum between Early Repolarization and Brugada Syndrome Antzelevitch C. - Utica, USA

• Panel consensus: How to Best Manage This Case

• Epilogue: SCD in 2012 Breithardt G. - Münster, DEU


Cardiostim 2012



32

Advance program


Educational Symposium of the International Society for Holter and Noninvasive Electrocardiology (ISHNE)

Advances in Noninvasive ElectrocardiologyChairmen: Wojciech Zareba - Rochester, USASergio Dubner - Buenos Aires, ARG Arthur J. Moss - Rochester, USA

Wednesday June 13 / 9:00 - 10:30EARLY REPOLARIZATION: BENIGN VERSUS DANGEROUS?Chair: Stone P. H. - Boston, USATuritto G. - New York, USA

• Electrophysiology of Early Repolarization El-Sherif N. - New York, USA

• J Wave Syndrome and SCD TBD

• Early Repolarization in Athletes Corrado D. - Padua, ITA

• Current State of the Early Repolarization Research Stern S. - Tel-Aviv, ISR

Wednesday June 13 / 14:00 - 15:30QUESTIONS IN OPTIMIZING BENEFITS OF CRTChair:Moss A. J. - Rochester, USAHaigney M. - Bethesda, USA

• CRT in RBBB Patients – Should We Abandon It? Zareba W. - Rochester, USA

• How Important Is the CRT Lead Location? Klein H. - Munchen, DEU

• Optimizing AV and VV Interval in CRT Patients – Is It Needed? Schuger C. - Detroit, USA

• CRT in Atrial Fibrillation Patients – Who and How? Steinberg J. - New York, USA

Wednesday June 13 / 16:00 - 17:30 CHALLENGING ECG DIAGNOSISModerators:Dubner S. - Buenos Aires, ARGSteinberg J. - New York, USA Piotrowicz R. - Warsaw, POL

Thursday June 14 / 9:00 - 10:30UPDATE ON METHODS IN THE RISK STRATIFICATION OF SCDChair:Hombach V. - Ulm, DEUOto A. - Ankara, TUR

• ST Segment and NSVT – Revival of Classical Parameters? Stone P. H. - Boston, USA

• Holter-Based T Wave Alternans – How to Analyze It? Verrier R. L. - Boston, USA

• Exercise-Induced T Wave Alternans – Is It Here to Stay? Klingenheben T. - Bonn, DEU

• HRV or QTV or Their Combination? La Rovere M. T. - Pavia, ITA

www.cardiostim.com


Thursday June 14 / 14:00 - 15:30RISK STRATIFICATION OF SUDDEN AND TOTAL MORTALITY IN SPECIFIC GROUPSChair: Dubner S. - Buenos Aires, ARGGoldberger J. - Chicago, USA

• Risk Stratification in Post-MI PCI-Treated Patients Exner D. - Calgary, CAN

• Risk Stratification in Diastolic Heart Failure TBD

• Risk Stratification in Diabetes Hombach V. - Ulm, DEU

• Risk Stratification in Atrial Fibrillation Patients Lombardi F. - Milan ITA

Thursday June 14 / 16:00 - 17:30CHALLENGING ECG DIAGNOSIS: VT OR SVTModerators:Breithardt G. - Münster, DEUSchuger C. - Detroit, USA

Friday June 15 / 9:00 - 10:30QT VARIABILITY AND DYNAMICS Chair:Verrier R. L. - Boston, USALa Rovere M. T. - Pavia, ITA

• QT Variability Haigney M. - Bethesda, USA

• QT Beat-to-Beat in Drug Studies Couderc JP. - Rochester, USA

• Exercise-Induced QT Changes TBD

• QT/RR Slope Locati E. - Milano, ITA

Friday June 15 / 14:00 - 15:30UPDATE ON INHERITED ARRHYTHMIA DISORDERS: DON’T MISS THE DIAGNOSIS - CASE-BASED PRESENTATION Chair:Locati E. - Milano, ITA Zareba W. - Rochester, USA

• Long QT Syndrome Moss A. J. - Rochester, USA

• ARVC Marcus F. - Tucson, USA

• Brugada Syndrome Breithardt G. - Münster, DEU

• Anderson-Tawil Syndrome Tristani-Firouzi M. - Salt Lake City, USA

Friday June 15 / 16:00 - 17:30CHALLENGING EGMS: APPROPRIATE OR INAPPROPRIATE ICD THERAPY - INTERACTIVE SESSION Moderators: Turitto G. - New York, USA Rabinovitz R. - Buenos Aires, ARG Ritter P. - Bordeaux, FRA


Cardiostim 2012

34

Advance program

Main Trials in the Management of Atrial Fibrillation Chairmen: Waldo A.L. - Cleveland, USACamm A.J. - London, GBRPratt C. - Houston, USA

Wednesday June 13 / 09:00 - 10:30THE NEW ORAL ANTICOAGULANTS (OACs) FOR STROKE PREVENTION IN AF - Part 1Chair: Waldo A. L. - Cleveland, USA

• ROCKET AF - Rivaroxaban for the Treatment of Atrial Fibrillation Breithardt G. - Münster, DEU

• Rivaroxaban in DVT and ACS Trials - An OAC for All Seasons? Verheught F. W. A. - NLD

• Dabigatran AF Sub-Studies Hohnloser S. - Frankfurt, DEU

Wednesday June 13 / 11:00 - 12:30THE NEW ORAL ANTICOAGULANTS (OACS) FOR STROKE PREVENTION IN AF - Part 2Chair: Camm A. J. - London, GBR

• ARISTOTLE (Apixaban) Wallentin L. - Uppsala, SWE

• AVERROES – Implications for Apixaban in Other Trials Waldo A. - Cleveland, USA

• ENGAGE AF – (Edoxaban) Weitz J. - Toronto, CAN

Wednesday June 13 / 14:00 - 15:30CLINICAL TRIALS IN AF - INFLUENCE ON GUIDELINES - DISCUSSION AND PERSPECTIVEChair: Pratt C. M. - Houston, USA

• Ventricular Rate Control [Really RATE II in perspective] van Gelder I. C. - Groningen, NLD

• Rhythm Control [includes prior Rate vs Rhythm trials and dronedarone story] Saksena S. - New Brunswick, USA

• Devices (BiV pacemakers, ICDs, etc.) Daubert J. C. - Rennes, FRA

Wednesday June 13 / 16:00 - 17:30AF ABLATION TRIALSChair: Page R. L. - Seattle, USA

• Late Follow-Up – Efficacy and Safety Kuck K. H. - Hamburg, DEU

• Ongoing Trials Ruskin J. N. - Boston, USA

• Ablation in Heart Failure Jaïs P. - Bordeaux, FRA

www.cardiostim.com


Cardiostim 2012

Acute Cardiac Care: Management of SCD

Session organized in cooperation with the Working Group on Acute Cardiac Care of the European Society of Cardiology (ESC)Chairmen: Vrints C. - Edegem, BELGorenek B. - Eskisehir, TUR

Wednesday June 13 / 11:00 - 12:30ARRHYTHMIAS IN PRIMARY PCIChair: Clemmensen P. M. - Copenhagen, DNK Quinn T. - GBR

• Incidence and Prognostic Impact Lettino M. - Roma, ITA

• How to Prevent and Manage Reperfusion Arrhythmias Gorenek B. - Eskisehir, TUR

• New Onset Atrial Fibrillation Manolis A. S. - Athens, GRC

• Coronary Intervention during VF /VT or Asystole Clemmensen P. M. - Copenhagen, DNK

Thursday June 14 / 09:00 - 10:30ARRHYTHMIAS IN ACUTE CARDIAC CARE SETTINGChair: Vrints C. - Edegem, BELN. Danchin - Paris, FRA

• Acute Arrhythmias in Adult Congenital Heart Disease Price S. - GBR

• Atrial Fibrillation in Patients with Acute MI; Prognostic Impact and Treatment Options Zeymer U. - DEU

• Atrial Fibrillation in Acute Heart Failure Vrints C. - Edegem, BEL

• Electrical Storm in Patients with ICD Santini M. - Roma, ITA



36

Advance program

Pacing, ICDs and CRTCourse Directors Hayes D. - Rochester, USARitter P. - Bordeaux, FRA & Bordeaux TeamCannom D. S. - Los Angeles, USASingh J. - Boston, USAAbi-Samra F. - New Orleans, USA

CRT

Wednesday June 13 / 09:00 - 10:30SELECTION OF CRT PATIENTS: GUIDELINES AND BEYONDChair: Mabo P. - Rennes, FRA Kottkamp H. - Zurich, CHE

• CRT Guidelines: Interpretation and Differences of ESC & American Guidelines TBD

• Patient with QRS between 120 and 150 ms: Are They Candidates for CRT? Holmeister J. - Zurich, CHE

• Should CRT Be Implemented during or after Cardiac Surgery in Patients with Low LVEF? Leclercq C. - Rennes, FRA

• Should CRT Be Routinely Used in patients with Spontaneous Complete Heart Block and after AVN Ablation? Gutleben K. J. - Bad Oeynhausen, DEU

• Should Patients with RBBB Be Implanted with a CRT Device? Botto G. - Como, ITA

Wednesday June 13 / 11:00 - 12:30CAN RESPONSE TO CRT BE BETTER PREDICTED BY…Chair: Butter C. - Bernau, DEU Defaye P. - Grenoble, FRA

• Scar Zone Location and Transmurality? Mela T. - Boston, USA

• Limited Regional Delayed Contraction in Recommended Candidates? Spragg D. - USA

• Assessment of Segmental Contractile Reserve? Gasparini M. - Rozzano (MI), ITA

• Presence of Co-Morbidities (RV Dysfunction, Renal Failure, Ageing, Diabetes etc..)? Van Bommel R. - Leiden, NLD

www.cardiostim.com


Cardiostim 2012

Pacing, ICDs and CRT

Wednesday June 13 / 14:00 - 15:30DURING IMPLANTATION, CAN CRT BE OPTIMIZED DURING IMPLANT BY…Chair: Ellenbogen K. - Richmond, USA

• Localization of Time-Delayed Activated Areas and Scar Zones? Rinaldi A. - London, GBR

• Change in QRS Width and/or Morphology? Daubert J. C. - Rennes, FRA

• Real-Time Echo Assessment? Van Bommel R. - Leiden, NLD

• Measurement of Hemodynamic Parameters? Whinnett Z. - London, GBR

Wednesday June 13 / 16:00 - 17:30TECHNIQUES FOR LV LEAD PLACEMENTChair: Gras D. - Nantes, FRA Belott P. H. - El Cajon, USA

• Balloon Anchoring Cha Y. M. - Rochester, USA

• Coronary Venoplasty TBD

• Snares Worley S. - Lancaster, USA

• Transeptal Derval N. - Bordeaux, FRA

Thursday June 14 / 11:00 - 12:30ROLE OF DIFFERENT PROVIDERS TO ASSURE CRT SUCCESSChair: Vogt J. - Bad Oeynhausen, DEU Lau C. P. - Hong Kong, CHN

• What Can Surgeons Add to the Care/Success of CRT Patients? Jansens J. L. - Brussels, BEL

• What Can EP Specialists Do for CRT Patients? Hayes D. - Rochester, USA

• What Can Heart Failure Experts Do for CRT Patients? Parks K. A. - Boston, USA

• What Can Specialists In Imaging Techniques Do for CRT Patients? Cochet H. - Bordeaux, FRA

38

Advance program


Thursday June 14 / 14:00 - 15:30YOUR OPINION - CRT ISSUES - PART IChair: Linde C. M. - Stockholm, SWE Oto A. - Ankara, TUR

• Pro - There Is a Role for CRT in Patients with Narrow (< 120 ms) QRS Ruschitzka F. - Zurich, CHE

• Contra - There Is a Role for CRT in Patients with Narrow (< 120 ms) QRS Beshai J. F. - Chicago, USA

• CRT in Heart Failure Patients with Preexistent or New Persistent Atrial Fibrillation - I Ablate the His Bundle Leclercq C. - Rennes, FRA

• CRT in Heart Failure Patients with Preexistent or New Persistent Atrial Fibrillation - I Ablate the Atria Singh J. - Boston, USA

Thursday June 14 / 16:00 - 17:30YOUR OPINION - CRT ISSUES - PART IIChair: Abi-Samra F. M. - New Orleans, USA Lewalter T. - Bonn, DEU

• Pro - Some Patients with LBBB Can Be Cured Thanks to the CRT Blanc J. J. - Brest, FRA

• Contra - Some Patients with LBBB Can Be Cured Thanks to the CRT Jourdain P. - Pontoise, FRA

• Pro - Now, I Apply CRT only in Heart Failure Patients with QRS ≥ 150ms Kautzner J. - Praha, CZE

• Contra - Now, I Apply CRT only in Heart Failure Patients with QRS ≥ 150ms Linde C. M. - Stockholm, SWE

Friday June 15 / 09:00 - 10:30YOUR OPINION - CRT ISSUES - PART IIIChair: Biffi M. - Bologna, ITA Prinzen F. W. - Maastricht, NLD

• Pro - Endocardial LV Pacing Is Better than Epicardial LV Pacing Singh J. - Boston, USA

• Contra - Endocardial LV Pacing Is Better than Epicardial LV Pacing Derval N. - Bordeaux, FRA

• Pro - CCM Is an Efficient Therapy for Heart Failure Ricci R. - Rome, ITA

• Contra - CCM Is an Efficient Therapy for Heart Failure Butter C. - Bernau, DEU

Friday June 15 / 11:00 - 12:30CRT ISSUES - PART IV: OPINIONS REGARDING TECHNIQUES FOR LV LEAD PLACEMENTChair: Israel C. W. - Bielefeld, DEU Abi-Samra F. M. - New Orleans, USA

• I Choose That Sheath in That Case Morgan J. M. - Southampton, GBR

• I Choose That Lead in That Patient Gras D. - Nantes, FRA

• I Decide to Stop or Continue the Procedure in That Case (Reference to Complications and Duration of Procedure) Worley S. - Lancaster, USA

www.cardiostim.com


Cardiostim 2012


Friday June 15 / 14:00 - 15:30FOLLOW-UP OF CRT PATIENTSChair: Ricci R. - Roma, ITA

• Management of Non-Responders Parks K. A. - Boston, USA

• Management of Super Responders Stellbrink C. - Bielefeld, DEU

• Management of AF Leyva F. - Sutton Coldfield, GBR

• Management of VAs (from PVCs to Sustained VT) Mittal S. - New York City, USA

Friday June 15 / 16:00 - 17:30HOW TO IDENTIFY RESPONDERS / NON-RESPONDERS TO CRT?Chair: Blanc J. J. - Brest, FRA Ovsyshcher E. - Beersheva, ISR

• Should a Universal Definition of a CRT-Responder Be Agreed Upon? TBD

• How to Assess Responders in NYHA I-II Heart Failure Patients? Linde C. M. - Stockholm, SWE

• How to Assess CRT Response in Non-Compliant Patients? Gold M. - Charleston, USA

• Are There Specific Criteria to Identify Super Responders before and during Implantation? Reynolds D. W. - Oklahoma City, USA



40

Advance program


Wednesday June 13 / 11:00 - 12:30SHOULD WE IMPLANT THOSE PATIENTS?Chair: Ruffy R. - Salt Lake City, USA Sulke N. - Eastbourne, GBR

• Conduction Disorders after TAVI Dos Santos P. - Bordeaux, FRA

• Nocturnal Bradycardia with and without Sleep Apnea Nielsen J. C. - Aarhus, DNK

• Drug-Induced Bradycardia Adragao P. - Lisbon, PRT

• Myotonic Dystrophy (Steinert Disease) Lazarus A. - Paris, FRA

Thursday June 14 / 09:00 - 10:30CHALLENGES OF ICD THERAPY - PART I: FUNCTIONING AND CHOICE OF THE DEVICEChair: Israel C.W. - Bielefeld, DEU Delnoy P.P. - Zwolle, NLD

• Five ICD Manufacturers: Specificities for Detection, Discrimination and Therapies Bordachar P. - Bordeaux, FRA

• The Specific Features of the Different ICDs Available Influence My Choice Ellenbogen K. - Richmond, USA Cannom D. S. - Los Angeles, USA

Thursday June 14 / 11:00 - 12:30CHALLENGES OF ICD THERAPY - PART II: PROGRAMMING THE DEVICEChair: Cannom D. S. - Los Angeles, USA Lubinski A. - Lodz, POL

• Young Patient with Normal Heart (Brugada, Long QT, Idiopathic VF) TBD

• Ischemic Heart Disease & Primary Prevention Mittal S. - New York City, USA

• Young Patient with Hypertrophic Cardiomyopathy (Obstructive and Non-Obstructive) Ellenbogen K. - Richmond, USA

• Impact of Drugs on ICD Programming (Clinical Cases) Klein H. - Rochester, USA

www.cardiostim.com

PACING AND ICD


Cardiostim 2012


Thursday June 14 / 14:00 - 15:30CHALLENGES OF ICD THERAPY - PART III: MANAGEMENT OF ELECTRICAL STORMS AND INAPPROPRIATE SHOCKSChair: Hayes D. - Rochester, USA Mabo P. - Rennes, FRA

• Drugs for Recurrent VAs in ICD Patients Giudici M. - Davenport, USA

• Catheter Ablation in ICD Patients Maury P. - Bordeaux, FRA

• Decision Making Process for ICD Lead Change Hauser R. - Long Lake, USA

• Broken Lead in a System That Never Recorded VAs: Extract, Replace or Remove Everything? Neuzil P. - Praha, CZE

Thursday June 14 / 16:00 - 17:30CHALLENGES OF ICD THERAPY - PART IV: DIFFICULT DECISIONSChair: Binner L. - Ulm, DEU Varma N. - Cleveland, USA

• ICD for Elderly Patients: What Is the Limit and when Should We Consider ICD Deactivation? Hayes D. - Rochester, USA

• Driving for ICD Recipients: Where Are the International Rules? Albert C. - Boston, USA

• ICD Recipients at Work: Impact of Environment TBD

Friday June 15 / 09:00 - 10:30SUBCUTANEOUS ICDS: A PATH TO A TECHNOLOGICAL REVOLUTIONChair: Borggrefe M. - Mannheim, DEU Murgatroyd F. D. - Cambridge, GBR

• Tolerance of the Material and Efficacy of Arrhythmia Detection Bardy G. H. - Seattle, USA

• Data Based on Clinical Studies Exner D. - Calgary, CAN

• A Specific Population for SQ ICDs? Jordaens L. - Rotterdam, NLD

Friday June 15 / 11:00 - 12:30YOUR OPINION Chair: Ritter P. - Bordeaux, FRA Reynolds D. W. - Oklahoma City, USA

• Leadless ICD and Leadless Pacemaker Wilkoff B. L. - Cleveland, USA Brachmann J. - Coburg, DEU

• Implantation of ICDs for Primary Prevention in Patients Older than 80 Years Benditt D. G. - Minneapolis, USA Klein H. - Rochester, USA

42

Advance program


Wednesday June 13 / 11:00 -12:30ART OF TIMING (PART I)Chair: Ronaszéki A. - Budapest, HUN Chirife R. - Buenos Aires, ARG

• The Concept of Optimal AV Delay Ronaszéki A. - Budapest, HUN

• Impact of Inter- and Intra-Atrial Conduction Delays on Optimal AV Interval Saksena S. - New Brunswick, USA

• What Can We Learn from Computer Simulations of AV- and VV-Delay Optimization? Lumens J. - Maastricht, NDL

• Effect of Heart Rate and Exercise on Optimal AV Interval Israel C. W. - Bielefeld, DEU

Wednesday June 13 / 14:00 - 15:30ART OF TIMING (PART II)Chair: Ronaszéki A. - Budapest, HUN Chirife R. - Buenos Aires, ARG

• Different Methods for Hemodynamic Optimization Gold M. - Charleston, USA

• How Efficient Are the Automatic Features of Implantable Devices? Lunati M. - Milano, ITA

• Round Table: AVD and V-V Interval Optimization in CRT: How Is This Best Accomplished? Singh J. - Boston, USA Gold M. - Charleston, USA Lunati M. - Milano, ITA Abi-Samra F. M. - New Orleans, USA

www.cardiostim.com

✓ Subscribe to Cardiostim newsletter on www.cardiostim.com


Cardiostim 2012

Leads

Pacing and ICD LeadsChair:J. Helland - Sylmar, USA

Wednesday June 13 / 14:00 - 15:30WHAT ARE ENGINEERS DOING TO IMPROVE CARDIAC LEAD FUNCTION & RELIABILITY?Chair: McVenes R. - Mounds View, USARicci R. - Rome, ITA

• What New Standardized Testing of Leads Will Be Implemented by Manufacturers: An AAMI CRMD Cooke D. - St Paul, USA

• What Does a Physician Extractor Need to Know about the Design of Cardiac Leads? Marshall M. - Minneapolis, USA

• Clinical Safety & Reliability Performance Update of DF4 Connector Systems Helland J. R. - Sylmar, USA

• How Does the Implant Technique & Location Affect the Forces & Stresses Applied to Implanted Leads? Binner L. - Ulm, DEU

• What Have Engineers Learned from Analyzing Force Loading and Use Conditions on Implanted Leads? Baxter W. - Minneapolis, USA

Wednesday June 13 / 16:00 - 17:30WHAT ARE PHYSICIANS LEARNING THAT NEEDS IMPROVEMENT IN CARDIAC LEADS?Chair: Helland J. R. - Sylmar, USAKennergren C. - Göteborg, SWE

• Multi-Electrode LV Leads: What Should the Electrode Spacing Be and Why? Thibault B. - Montreal, CAN

• When Transvenous LV Leads Won’t Work – EP Implantation of Cardiac Leads in the Pericardial Space Jaïs P. - Bordeaux, FRA

• What Improvements Are Needed in Lead Design and Materials to Reduce Patient Risk and Increase Reliability of Successful Extractions? Schaerf R. - Burbank, USA

• What Is the Proper Way to Place the Device & Lead in the Pocket and to Anchor Lead Suture Sleeves and What Is Needed for the Future? Skehan J. D. - Leicester, GBR

• What Does a Physician Need to Consider When Using MRI Safe Systems Regarding Lead Abandonment vs Extraction? Bongiorni M. G. - Pisa, ITA

44

Advance program

Leads

Lead ManagementOrganized by Kennergren C. - Göteborg, SWE

Wednesday June 13 / 14:00 - 15:30CIED PATIENT INFECTIONChair: Wilkoff B. L. - Cleveland, USANeuzil P. - Praha, CZE • What Leads Should/Should Not Be Removed According to

EHRA and HRS Recommendations? Deharo J. C. - Marseille, FRA

• What Are the Present Results of Lead Extraction in High, Medium and Low Volume Centers? Pelargonio G. - ITA

• Management of Superfluous Leads; Should All Superfluous Leads Be Extracted? Butter C. - Bernau, DEU

• Management of Recalled Leads; What Leads in Which Patients Should and Should Not Be Extracted? Birgersdotter Green U. - San Diego, USA

Thursday June 14 / 09:00 - 10:30LEAD MANAGEMENTChair: Epstein L. - Boston, USABongiorni M. G. - Pisa, ITA

• Categories, Incidences, Causes and Outcomes Bracke F. - NLD

• Diagnosis, Pharmacological Treatment and Timing of Extraction Blum T. - Bad Krozingen, DEU

• Transvenous Extraction, Surgical Extraction and Local Revision Fischer A. - USA

• Timing of Re-Implantation and Treatment of PM Dependent Defaye P. - Grenoble, FRA

Thursday June 14 / 14:00 - 15:30PERFORMING LEAD EXTRACTIONChair: Klug D. - Lille, FRA

• Training and Site Requirements Mitkowsky P. - Poznan, POL

• Transvenous Lead Extraction from the Route of Implantation; Available Techniques Rinaldi A. - London, GBR

• Femoral, Transjugular, Surgical, Hybrid and Other Non Standard Lead Extraction Techniques Love C. - Columbus, USA

• Treatment of Lead Extraction Complications Kennergren C. - Göteborg, SWE

www.cardiostim.com


Cardiostim 2012

Associate Symposia

Cardiostim/HRS Joint Session

Friday June 15 / 09:00 - 10:30THE 2012 HRS / EHRA / ECAS CONSENSUS DOCUMENT ON CATHETER AND SURGICAL ABLATION OF ATRIAL FIBRILLATIONChair: Calkins H. - Baltimore, USA

• Introduction and Overview of the Recommendations Calkins H. - Baltimore, USA

• Strategies for Anticoagulation: What Does the Consensus Document Tell Us? DiMarco J., USA

• Implications for the Design of Clinical Trials of AF Ablation Packer D. L. - Rochester, USA

• Guidelines from Around the World: How Do They Compare? Gillis A. M. - Calgary, CAN

CardiopaceOrganized by Jazra C. - Beirut, LBN

Wednesday June 14 / 16:00 - 17:30LVH AND SUDDEN DEATH: FROM CLASSIFICATION TO MANAGEMENTChair: Al Fayyad M. - KSAKhoury M. - Beirut, LBN

• Echo versus ECG Classification of LVH Chamams E. - Beirut, LBN

• Mechanism of Arrhythmia in Patients with LVH Oto A. - Ankara, TUR

• Risk Assessment: What Do the Guidelines Tell Us? Veltmann C. - DEU

• Hypertension and LVH: Determinants of Risk Jazra C. - Beirut, LBN

Vaso Vagal SyncopeOrganized by Blanc J. J. - Brest, FRA

Thursday June 14 / 11:00 - 12:30VASO VAGAL SYNCOPE: THERE ARE NEW DATA!Chair: Alboni P. - Ferrara, ITASutton R. - Monte-Carlo, MCO

• What Is Vaso Vagal Syncope: Physiopathology, Genetics and Diagnosis? Benditt D. G. - Minneapolis, USA

• Vaso Vagal Reactions in Animals to Vaso Vagal Syncope in Humans: Identical or Different? Blanc J. J. - Brest, FRA

• When and How to Treat Vaso Vagal Syncope (Except by Pacing)? Ammirati F. - Roma, ITA

• Pacing in Vaso Vagal Syncope: From VPS I to ISSUE III Brignole M. - Lavagna, ITA

46

Advance program

Associate Symposia

Geriatric CardiologyOrganized by Shen W. - Scottsdale, USAVlietstra R.E. - Lakeland, USAMunger Thomas T. - Rochester, USA

ARRHYTHMIA MANAGEMENT IN OLDER PERSONS WITH A FOCUS ON CASE BASED DISCUSSION

Thursday June 14 / 09:00 - 10:30FAINTING AND FALLS: HOW CAN WE MAINTAIN THE UPRIGHT POSITION AS WE GET OLDER?Chair: Benditt D. G. - Minneapolis, USARaviele A. - Venice, ITA

• State-of-the-Art Lecture: Aging and Autonomic Regulation: Physiology and Clinical Relevance Low P. - Rochester, USA

Case Presentation and Panel Discussion

• CASE 1: 84 yr W, Diabetic w/ Parkinson’s & recurrent syncope TBD

• CASE 2: 88 yr M, dementia, LBBB, 1 year H/O recurrent syncope Parry S. W. - New Castle, GBR

• CASE 3: 87 yr M, anemia, EF 30%, palpitations & near syncope x 2 TBD

Thursday June 14 / 11:00 - 12:30ATRIAL FIBRILLATION & STROKE PREVENTION: NEW TECHNIQUES, NEW TECHNOLOGY, NEW ANTICOAGULANTS & NEW DRUGS FOR THE ELDERLYChair: Gaita F. - Torino, ITAMunger T. - Rochester, USA

• State-of-the-Art Lecture: AF in the Elderly: Drugs, Ablation and Devices Calkins H. - Baltimore, USA


• CASE 1: 86 yr W, HTN, Diabetic w/ 2 recurrent TIAs in setting of PAF, GI bleeds/falls Friedman P. - Rochester, USA

• CASE 2: 90 yr M, persistent AF, HTN, CHF, and COPD Shen W. - Scottsdale, USA

• CASE 3: 85 yr retired surgeon runs marathon, sinus bradycardia and symptomatic PAF Hocini M. - Bordeaux, FRA

www.cardiostim.com


Cardiostim 2012

Associate Symposia

Thursday June 14 / 14:00 - 15:30PACEMAKER & ICD: WHEN DO WE SAY YES AND WHEN DO WE SAY NO?Chair:Hammill S. - Rochester, USAGillis A. M. - Calgary, CAN

• State-of-the-Art Lecture: Pacemaker and ICD: Implantation, Withhold and Withdraw Therapy TBD


• CASE 1: 82 yr M, CAD, prior EF 32%, NYHA III, NSTEMI 3 days ago, SR 34 bpm, EF 30% Cha Y-M. - Rochester, USA

• CASE 2: 89 yr W, independent, DCM, NYHA II, EF 25%, not PM dependent, ICD at ERI Jahangir A. - Milwaukee, USA

• CASE 3: 92 yr W, PAF, daytime pauses of 4.2 seconds, EF 55%, no symptoms Srivathsan K. - Scottsdale, USA

Thursday June 14 / 16:00 - 17:30HEART FAILURE AND CARDIAC IMAGING: SPECIAL CONSIDERATIONS AND RELEVANT ISSUES IN THE ELDERLYChair:Vlietstra R. - Lakeland, USAWilkoff B. - Cleveland, USA

• State-of-the-Art Lecture: Heart Failure in the Elderly: Knowledge Gaps in CRT TBD


• CASE 1: 83 yr M, prior MI NYHA III CHF, COPD, QRS duration 120 ms, Echo EF 30% Lee H-C. - Rochester, USA

• CASE 2: 88 yr W, renovascular HTN, PVCs, Sestamibi EF 60%, NYHA III CHF symptoms Zieman S. - Bethesda, USA

• CASE 3: 86 yr W, DOE on golf course, EF 48%, dense LMCA/LAD CA++, elevated BNP Behrenbeck T. - Rochester, USA

48

Advance program

Associate Symposia

Asia Pacific Cardiostim SymposiumUnder the Auspices of the Asia Pacific Society of CardiologyOrganized by Sethi K. - New Delhi, IND Vohra J. - Melbourne, AUSSloman G. - Richmond, AUS

Friday June 15 / 09:00 - 10:30MANAGEMENT OF ARRHYTHMIAS IN THE ELDERLY IN THE ASIAN PACIFIC REGIONChair: Sloman G. - Richmond, AUS Vohra J. K. - Melbourne, AUS

• Non-Ischaemic Ventricular Tachycardia in Asia Pacific: Regional Variation Sethi K. - New Delhi, IND

• Catheter Ablation of Ventricular Tachycardia in Hypertrophic Cardiomyopathy and Sarcoidosis Soejima K. - Kawasaki, JPN

• Catheter Ablation of Unusual Outflow Ventricular Tachycardia Kantharia B. - Columbus, USA

• Surgical Ablation of Non-Ischemic Ventricular Tachycardia Nitta T. - Tokyo, JPN

PalpitationsOrganized by Raviele A. - Venice, ITA

Friday June 15 / 09:00 - 10:30MANAGEMENT OF PATIENTS WITH PALPITATIONSChair: Prystowsky E. - Indianapolis, USARaviele A. - Venice, ITA

• Definition, Causes and Classifications Steinbeck G. - Munchen, DEU

• Diagnosis Strategy and Clinical Evaluation Blanc J. J. - Brest, FRA

• Ambulatory Electrocardiographic Monitoring Giada F. - Noale, ITA

• Electrophysiologic Study and Other Instrumental Investigations Blomstrom-Lundqvist C. - Uppsula, SWE

• How to Treat and When to Hospitalize Viskin S. - Tel Aviv, ISR

www.cardiostim.com


Cardiostim 2012

Associate Symposia

Fetal Cardiology SymposiumOrganized by Guirgis M. - Paris, FRA

Thursday June 14 / 11:00 - 12:30BASIC UNDERSTANDING AND EXPLORATION OF FETAL RHYTHMChair:Guirgis M. - Paris, FRA Squarcia U. - Parma, ITA

• Normal Development of Conductive System and Regulation of Fetal Rhythm: Substrate for Fetal Arrhythmias Blom N. - Leiden, NDL

• Classic and New Techniques in Evaluation of Fetal Rhythm Cuneo B. - Chicago, USA

• Telemedicine Role in Fetal Cardiology Cuneo B. - Chicago, USA

Thursday June 14 / 14:00 - 15:30FETAL ARRHYTHMIAS - PART IChair:Hornberger L.K. - Edmonton, CANJaeggi E. - CAN

• Update in Genetics Studies of Fetal Arrhythmias Priori S.G. - Pavia, ITA

• Diagnosis of Fetal Tachyarrhythmias Hornberger L.K. - Edmonton, CAN

• Diagnosis of Fetal Bradycardias Jaeggi E. - CAN

• How to Suspect Long QT in a Fetus? Cuneo B. - Chicago, USA

• Fetal heart failure in fetal arrhythmias: Mechanisms and echocardiographic presentations Silverman N. - USA

Thursday June 14 / 14:00 - 15:30FETAL ARRHYTHMIAS - PART II Chair:Silverman N. - USACuneo B. - Chicago, USA

• Pitfalls in Fetal Rhythm Diagnosis Blom N. - Leiden, NDL

• Fetal Therapy : Medical and Ethical Basis Guirgis M. - Paris, FRA

• Treatment Strategies of Fetal Tachyarrhythmias Hornberger L.K. - Edmonton, CAN

• Current Management of Auto Immune Av Block Jaeggi E. - CAN

• The Cardiac Fetus at Risk of Sudden Death Cuneo B. - Chicago, USA

PRACTICAL INTERACTIVE WORKSHOPChair: Jaeggi E. - CAN Hornberger L.K. - Edmonton, CAN

LIVE DEMONSTATIONS OF ECHODOPPLER TECHNICS FOR ANALYSIS OF FETAL RHYTHM

50

Advance program

Associate Symposia

Pediatric Cardiac ElectrophysiologyOrganized by Thambo J.B. - Bordeaux, FRA

Thursday June 14 / 09:00 - 10:30PITTFALLS AND PEARLS…• WPW and Supraventricular Tachycardia

Ernst S. - Hamburg, DEU

• Arrhythmias and Grown-Ups with Congenital Heart Defect Hebe J. - DEU

• Abnormal EKG or Not TBD

Thursday June 14 / 11:00 - 12:30HOT TOPIC IN PEDIATRIC PACING• Pediatric Pacing 30 Years after

Silvetti M. - Milano, ITA

• Alternative Approaches in Patients with Congenital Heart Disease Bordachar P. - Bordeaux, FRA

• Are There Indications for Prophylactic Leads Extraction in Pediatric Patient? Hidden Lucet F. - Paris, FRA

Thursday June 14 / 11:00 - 12:30CHANNELOPATHY IN PEDIATRICS: CASE REPORT, EKG• Brugada Syndrome

Brugada P. - Aalst, BEL

• Long QT Syndrome Wilde A. M. - Amsterdam Zuidoost, NLD

• ICD in Pediatrics Berul C. - Washington USA

Thursday June 14 / 14:00 - 15:30VENTRICULAR ARRYHTHMIAS AND SUDDEN DEATH IN CONGENITAL HEART DISEASE: CHALLENGES AND CREATIVE SOLUTIONSChair:Khairy P. - USA

• Risk Stratification for VT and Sudden Death in Congenital Heart Disease: When to Worry? Abadir S. - USA

• Optimizing ICD Programming In Congenital Heart Disease Mansour F. - USA

• VT Ablation in Congenital Heart Disease: Lessons Learned from Acquired Heart Disease Sacher F. - Bordeaux, FRA

Cardiostim – Japanese Heart Rhythm Society (JHRS) Joint SymposiumChair: Nakazato Y. - Tokyo, JPNCazeau S. - Paris, FRA

Friday June 15 / 11:00 – 12:30• Physiology of the Failing Heart

TBD

• Narrow QRS Patients: Is the Story Over? Anselme F. - Rouen, FRA

• Ablation of the Benign VT? Uno K. - Tokyo, JPN

• Brugada Syndrome Management - The Japanese Position Takagi M. - Osaka, JPN

www.cardiostim.com


Cardiostim 2012

Associate Symposia

SyncopeOrganized byFlammang D. - Lyon, FRA

Friday June 15 / 11:00 - 12:30UNDERSTANDING SYNCOPE Chair: Kenny R. A. - Dublin, IRLFlammang D. - Lyon, FRA

• Neurophysiology of TLOC: Syncope and Non-Syncope Ryvlin P. - Lyon, FRA

• Physiopathology of CSM Parry S. W. - Newcastle Upon Tyne, GBR

• Syncope and Channellopathies Abi-Samra F. M. - New Orleans, USA

• New Research Pathways in Syncope Benditt D. G. - Minneapolis, USA

• Test in the Management of Syncope: Basic Aspects of Data Interpretation Pelleg A. - Philadelphia, USA

Friday June 15 / 14:00 - 15:30CLINICAL CASES ON SYNCOPEChair: Parry S. W. - Newcastle Upon Tyne, GBRBlanc J. J. - Brest, FRA

• CLINICAL CASES Parry S. W. - Newcastle Upon Tyne, GBR Benditt D. G. - Minneapolis, USA Pruvot E. - Lausanne, CHE Flammang D. - Lyon, FRA Deharo J. C. - Marseille, FRA Blanc J. J. - Brest, FRA

ICE Program Organized by Saksena S. - Warren, USA

Thursday June 14 / 09:00 - 10:30INNOVATIONS IN INTRACARDIAC ECHOCARDIOGRAPHY: NOVEL APPLICATIONS AND EVIDENCE BASED EVALUATIONChair: Saksena S. - Warren, USA

• Importance and Limitations of Imaging Techniques in Left Ventricular Lead Placement For Cardiac Resynchronization Desai M. - Cleveland, USA

• Advances in ICE Based Analyses of Left Ventricular Function Di Biase L. - Austin, USA

• ICE Guided CRT: Design and Implications of an Evidence Based Approach – The CHOICE Study Saksena S. - Warren, USA

• Left Atrium and Appendage Imaging with ICE: Technologic Advances and Unconventional Approaches Liu C. F. - New York, USA

• ICE Guided Cardioversion: Are We Ready for Clinical Trials? Jordaens L. - Rotterdam, NLD

52

Advance program

Associate Symposia

Friday June 15 / 14:00 - 15:30EP: WHAT’S HOT, WHAT’S NOT, WHAT’S TOUGHChair: Poole J. E. - Washington, USAHoffmann E. - Munchen, DEU

• AF Ablation: Beyond Pulmonary Vein Isolation – Case studies Ernst S. - London, GBR Eisenberg S. - Walnut Creek, USA

• Controversies in Lead Extractions for Non-Infectious Indications Birgersdotter- Green U. - San Diego, USA Bongiorni M. G. - Pisa, ITA

• Complex VT Ablation: When the Going Gets Tough Chung M. - Cleveland, USA Blomström-Lundqvist C. - Upsala, SWE

• Discussion / Q&A

EPIC Alliance

The EPIC Alliance is designed to provide global networking, professional development, and exclusive research opportunities for female Electrophysiologists.

The vision of the EPIC Alliance is to enrich and diversify the field of Electrophysiology by building a global network of women Electrophysiologists at all level of experience that will create a community of collaboration, mainly by mentoring. It provides peer information on how to balance personal and professional issues, offers opportunities for clinical research projects and enables leadership and career development.

www.cardiostim.com

Italian Cardiostim SymposiumOrganized by Santomauro M. - Naples, ITA

Friday June 15 / 14:00 - 15:30SPORT PRACTICE IN PACEMAKER AND ICD PATIENTSChair:Bongiorni M. G. - Pisa, ITA

• Update on Prevention of Dangerous Leads in the Athletes with Pacemaker Delise P. - Conegliano Veneto, ITA

• Update on Prevention of Dangerous XXX in the Athletes with ICD Padeletti L. - Firenze, ITA

• Commotio Cordis in Young Athletes: How to Prevent It? Gaita F. - Asti, ITA

• Sudden Death in Athletes: The Role of the PM and the ICD Lunati M. - Milano, ITA

• Management of the Syncope in Athletes with Implantable Devices Inama G. - Crema, ITA

Friday June 15 / 14:00 - 15:30SUDDEN DEATH IN HOSPITAL AND OUT OF HOSPITAL: NEW AUTOMATIC EXTERNAL DEFIBRILLATION ON-LINEChair: Gulizia M. - Catania, ITASantomauro M. - Napoli, ITA • The Network of AED in Hospital

Cappato R. - San Donato Milanese, ITA

• AED in Hospital: The Impact of the 2010 ILCOR Guidelines Montenero A. - Sesto San Giovanni (Milan), ITA

• Applicability of New AEDs on Line during Sports Events Giada F. - Noale, ITA

• Cost/Effectiveness of AEDs on Public Use Capucci A. - Ancona, ITA

• PAD Projects: Practical Training of First Responders Roscio G. - Roma, ITA

• Legal Issue on Public Use of AEDs with Remote Monitoring Riganti C. - Napoli, ITA


Cardiostim 2012

Industry Symposia

Thursday June 14 / 14:00 - 15:30NEW ADVANCES FOR PATIENTS WITH ATRIAL FIBRILLATIONChair: Camm A. J. - London, GBRHindricks G. - Leipzig, DEU

• Impact from Remote Monitoring on Anticoagulation Ip J. - Lansing, USA

• Ways to Reduce Inappropriate ICD Therapies in AF Bänsch D. - Rostock, DEU

• How to Achieve Reliable Cardiac Resynchronization in AF? Gras D. - Nantes, FRA

• Improving the Outcome of AF Ablation Kuck K. H. - Hamburg, DEU

Session made possible thanks to an educational grant from BIOTRONIK

Thursday June 14 / 14:00 - 15:30THE SUBCUTANEOUS ICDChair: Wilkoff B. L. - Cleveland, USAKlein H. - Rochester, USA

• Overview of the S-ICD System Cappato R. - San Donato Milanese (MI), ITA

• Results of the S-ICD System’s IDE Study Gold M. D. - Charleston, USA

• EFFORTLESS – The First Results Boersma L. - Nieuwegein, NLD

• The Future of ICD Therapy Morgan J. M. - Southampton, GBR

Session made possible thanks to an educational grant from CAMERON HEALTH

Friday June 15 / 11:00 - 12:30LAA CLOSURE FOR STROKE PREVENTION: WHAT EVERY ELECTROPHYSIOLOGIST SHOULD KNOWModerators:Camm A. J. - London, GBRSchumacher B. - Bad Neustadt/sale, DEU

• Is There a Room for a Device Alternative to Oral Anticoagulants (OAT) ? Camm A. J. - London, GBR

• LAAC with WATCHMANTM Device: Latest Clinical Evidences

• WATCHMAN: A Clinically Proven Therapy Reddy V. Y. - Boston, USA

• Patient Selection: Finding the Right Patient in the Right Place Schumacher B. - Bad Neustadt, DEU

• LAAC Implant: Practicing Our Knowledge on Real Cases Reddy V. Y. - Boston, USA

• Debate: LAAC & AFIB Ablation - Should We Perform Both Simultaneously? Pro: Boersma L. - Nieuwegein, NLD Contra: Schmidt B. - Hamburg, DEU

Session made possible thanks to an educational grant from BOSTON SCIENTIFIC

54

Advance program

Industry Symposia

Wednesday June 13 / 11:00 - 12:30DIAGNOSING AF: CAN WE PREVENT STROKES CAUSED BY AF?Chair: Krieger D. - Copenhagen, DNKHohnloser S. - Frankfurt, DEU

• More Intensive Monitoring Leads to More AF Detection Wachter R. - Göttingen, DEU

• AF Burden Is a Determinant Risk Factor for Stroke Boriani G. - Bologna, ITA

• Cryptogenic Stroke: Why Move Beyond the Guidelines? Cotter P. - Cambridge, GBR

• Screening High Risk Patients for AF through Continuous Monitoring Heinzel F. - Graz, AUT

Session made possible thanks to an educational grant from MEDTRONIC

Wednesday June 13 / 14:00 - 15:30TREATING AF: HOW TO EFFECTIVELY REDUCE STROKE RISK?Chair: Kirchhof P. - Birmingham, GBR Diener H.C. - Essen, DEU

• Stroke Prevention from the Cardiologist‘s Perspective Camm A. J. - London, GBR

• What We Need to Know about Strokes Caused by AF Thijs V. - Leuven, BEL

• New Drugs for Stroke Prevention Huber K. - Vienna, AUT

• Early PVI as a Treatment Option after Stroke Caused by AF Tondo C. - Milano, ITA

• Future Strategies for Device Therapy in AF Management Hill M. - Minneapolis, USA


Wednesday June 13 / 16:00 - 17:30EMERGING LEADERS IN ELECTROPHYSIOLOGY: CASE PRESENTATION AND DISCUSSIONChair: Prystowsky E. N. - Indianapolis, USA

• Faculty

Schalij M. - Leiden, NLD Priori S. G. - Pavia, ITA Borggrefe M. - Mannheim, DEU

• Case Report 1 Bianchi S. - Roma, ITA

• Case Report 2 Thomas D. - Heidelberg, DEU

• Case Report 3 Duparc A. - Toulouse, FRA

• Case Report 4 Brown B. - Manchester, GBR


www.cardiostim.com


Cardiostim 2012

Industry Symposia

Thursday June 14 / 11:00 12:30HOW TO INCREASE CRT RESPONSE?Chair: Gras D. - Nantes, FRACurnis A. - Brescia, ITA

• Defining CRT Response Leclercq C. - Rennes, FRA

• New Tools to Position the LV Lead at the Point of Latest Activation Cantu F. - Bergamo, ITA

• Continuous Automatic Adaptation of the AV and VV Interval Milasinovic G. - Belgrade, SRB

• Care Pathway of HF Patients: Improving Efficiency Wright J. - Liverpool, GBR


Thursday June 14 / 14:00 - 15:30PULMONARY VEIN ISOLATION: THE CORNERSTONE OF ATRIAL FIBRILLATION ABLATIONChair: Furniss S. - Eastbourne, GBRBlomstrom-Lundqvist C. - Uppsula, SWE

• Techniques for Catheter Ablation of Paroxysmal and Persistent Atrial Fibrillation: A Systematic Review Verma A. - New Market, CAN

• Cryoballoon Ablation of Pulmonary Veins: Global Clinical Experience Neumann T. - Bad Nauheim, DEU

• Duty Cycled Phased RF: Global Clinical Experience and Evolution Geller C. - Bad Berka, DEU

• Comparing Technologies: What Are the Impacts of Energy Source on Results? Schilling R. - London, GBR

• Early Ablation: Should Cryoballoon Ablation Be Proposed as First-Line Therapy? Chierchia G. - Brussels, BEL


56

Advance program

Industry Symposia

Friday June 15 / 09:00 - 10:30ICD THERAPY SAVES LIVES: DO YOU CARE?Chair: van Gelder I. C. - Groningen, NLDKacet S. - Lille, FRA

• Why Should We Care Implanting ICDs? Auricchio A. - Lugano, CHE

• Economics of ICD Therapy: Limitations of Cost Efficacy Braunschweig F. - Stockholm, SWE

• Role of Discrimination Algorithms to Prevent Inappropriate Shocks Gold M. - Charleston, USA

• New Solutions to Increase Benefits and Reduce Risks Gasparini M. - Rozzano (MI), ITA

• Innovative Tools to Improve Patient’s and Physician’s Lives Mason M. - Harefield, GBR


Friday June 15 / 11:00 - 12:30NEW ADVANCES IN TREATMENT OF PACEMAKER PATIENTSChair: Sperzel J. - Bad Nauheim, DEUSutton R. - Monte-Carlo, MCO

• Pacemaker Therapy in Vasovagal Syncope: ISSUE III Study Results Brignole M. - Lavagna, ITA

• Experience with MRI Safe Devices Weishaupt D. - Zurich, CHE

• The Importance of Device Detected Atrial Fibrillation Santini M. - Roma, ITA

• The Role of New Technology in Device Follow-Up Morgan J. M. - Southampton, GBR

• The Future of Bradycardia Pacing: Leadless Pacemakers Ritter P. - Bordeaux, FRA


www.cardiostim.com

Thursday June 14 / 9:00 - 10:30RAPID MAPPING AND CRT OPTIMIZATION WITH NONINVASIVE 3D ELECTROCARDIOGRAPHY: A NEW ERA!Mapping Chair: Haïssaguerre M. - Bordeaux, FRACRT Chair: Singh J. - Boston, USA

• Accurate Single Beat Mapping and Ablation of Premature Ventricular Beats Kanagaratnam P. - London, GBR

• Rapid Mapping of Focal Ventricular Arrhythmias – A Prospective Multi-Centric Evaluation Neumann T. - Bad Nauheim, DEU

• Electrical Synchrony: A Powerful Tool for Selection, Implantation and Optimization of CRT Ritter P. - Bordeaux, FRA

• Clinical Validation of Non-Invasive Electrocardiographic Mapping of Arrhythmias: A Multi-Center Experience Lindsay B. - Cleveland, USA

Session made possible thanks to an educational grant from CARDIOINSIGHT TECHNOLOGIES


Cardiostim 2012

Industry Symposia

Wednesday June 13 / 11:00 - 12:30INNOVATION IN EP- ADDING NEW VALUES: CLINICAL APPROACHES AND THE LAB OF THE FUTURE• Recorded MediGuide Case with Velocity Integration from

Cotignola • Focus on Mediguide EP & CRM Tools

• MediGuide in Everyday Use

Session made possible thanks to an educational grant from ST JUDE MEDICAL

Wednesday June 13 / 16:00 - 17:30 St Jude Medical MEAChair: Al-Fagih A. - Riyadh, SAUCurnis A. - Brescia, ITA Jazra C. - Beirut, LBN

• Arrhythmia in ME: From Incidence to Solution

• The Evolving Landscape of Electrophysiology Services: Challenges and Opportunities

• Pacemaker Evolution: From Standard VVI to MRI Compatible

• What’s New in CRT: The Other Two Electrodes

• Afib Ablation: Usage of Different Technology for Complex Arrhythmia


Thursday June 14 / 09:00 - 10:30STATE-OF-THE-ART HF MANAGEMENT: FROM IMPLANT TO LONG-TERM FOLLOW-UP

• The Future of CRT Therapy : Addressing Common Pacing Complications and Minimizing Fluoro Exposure

• Improving CRT Response : Optimizing CRT Pacing and Assessment of Multipoint Pacing

• Advancement of HF Management : On the Cutting Edge


Thursday June 14 / 16:00 - 17:30EVERYTHING AND MRI: IS IT FOR EVERYBODY?• MRI & Medical Devices: Current Status

• New Pacemaker Generations and MRI – Current Status

• ICD’s and MRI, Is This Really MRI Conditional?

• Leadless Pacing – A Glimpse in the Future


58

Advance program

Industry Symposia

Wednesday June 13 / 14:00 - 15:30THE ROLE OF CARDIOLOGISTS IN SLEEP APNEA MANAGEMENTChair: Hayes D. - Rochester, USAGarrigue S. - Bordeaux, FRA

• Why Should Cardiologists Now Be Alert to Sleep Apnea? Darrel F. - London, GBR

• Prevalence and Mechanisms of Sleep Apnea Syndrome Skowasch D. - Bonn, DEU

• Contribution of Pacemaker Sensors to Provide Apnea /Hypopnea Index Defaye P. - Grenoble, FRA

• How Can Cardiologists Better Manage Sleep Apnea Patients? Bordier P. - Bordeaux, FRA

• Round Table Discussion

Session made possible thanks to an educational grant from SORIN GROUP

Thursday June 14 / 16:00 - 17:30 THE IMPORTANCE OF CRT OPTIMIZATION IN DAILY LIFE: ADDRESSING THE CHANGING PATIENT NEEDChair: Dickstein K. - Stavanger, NORPadeletti L. - Firenze, ITA

• Encountering Reverse Remodeling and Changing Patient Status: The Need for More Regular Optimization Sadoul N. - Nancy, FRA

• CRT Optimization to Improve Clinical Response: From CLEAR to RESPOND Trials Singh J - Boston, USA

• Case Presentation: Automatic Optimization of CRT Timing Oliveira M. - Lisbon, PRT

• Case Presentation: Adapting CRT Settings to Patient Activity Mansourati J. - Brest, FRA

• Round Table Discussion

Session made possible thanks to an educational grant from SORIN GROUP

Friday June 15 / 09:00 - 10:30LASER LEAD EXTRACTION: MOVING TO THE NEXT LEVELSession made possible thanks to an educational grant from

SPECTRANETICS

www.cardiostim.com


Cardiostim 2012

Symposium STIMUPRATOrganisé par Pierre Bordachar - CHU de Bordeaux, FRA Stéphane Garrigue - Bordeaux, FRASylvain Reuter - Bordeaux, FRAPhilippe Ritter - CHU de Bordeaux, FRAFrédéric Sacher - CHU de Bordeaux, FRA

Ce symposium est composé de 5 sessions présentées en français, à l’initiative de l’équipe bordelaise et selon une formule à succès déjà proposée en région Aquitaine depuis quelques années.

Ce symposium non sponsorisé sera accrédité par la Société Française de Cardiologie. L’objectif est d’expliquer de façon didactique le fonctionnement des prothèses cardiaques actives à partir de tracés électrocardiographiques et d’électrogrammes mémorisés, en utilisant directement en salle de conférence les programmateurs des différentes marques disponibles.

Le but est de travailler en live comme à la consultation, à partir de documents réels présentés selon un ordre logique et illustrant les situations les plus souvent rencontrées en stimulation cardiaque, défibrillation implantable et resynchronisation.

Une des 5 sessions est dédiée à des dossiers complexes associant les diverses thérapeutiques d’électrophysiologie chez les mêmes patients. La participation de tous est nécessaire afin d’enrichir les discussions que les organisateurs souhaitent transformer en staffs plus qu’en présentations formelles.

This non-sponsored symposium is composed of 5 sessions accredited by the French Society of Cardiology and will be given in French. Its objective is to explain the functioning of pacemakers, ICDs, and CRT devices from ECGs, and EGMs, using, -in the conference room-- the programmers of the 5 companies available. Presentations should rather become a staff discussion, meaning the active participation of attendees!

Vendredi 15 juin / 11:00 - 12:30LES THERAPIES HYBRIDES : PROTHESE IMPLANTABLE + ABLATION + MEDICAMENTS + … DU CABINET A LA SALLE D’ELECTROPHYSIOLOGIEModérateurs :

Frédéric Sacher - CHU de Bordeaux, FRA

Mark O’Neill - London, GBR

Serge Boveda - Toulouse, FRA

Pascal Defaye - Grenoble, FRA

Stéphane Garrigue - Bordeaux, FRA

Sylvain Reuter - Bordeaux, FRA

Vendredi 15 juin / 14:00 - 15:30LA CONSULTATION EN LIVE : FONCTIONNEMENT DES DEFIBRILLATEURS AUTOMATIQUES IMPLANTABLES A PARTIR DES PROGRAMMATEURS (D’UNE MARQUE A L’AUTRE)Modérateurs :

Pierre Bordachar - CHU de Bordeaux, FRA



Philippe Ritter - CHU de Bordeaux, FRA

Frédéric Anselme - Rouen, FRA



Nicolas Sadoul - Nancy, FRA

60

Advance program

Symposium STIMUPRAT

Vendredi 15 juin / 16:00 - 17:30LA CONSULTATION EN LIVE : FONCTIONNEMENT DES DEFIBRILLATEURS AUTOMATIQUES IMPLANTABLES A PARTIR DES PROGRAMMATEURS (D’UNE MARQUE A L’AUTRE)Modérateurs :








Nicolas Sadoul - Nancy, FRA

Samedi 16 juin / 09:00 - 10:30LA CONSULTATION EN LIVE : FONCTIONNEMENT DES STIMULATEURS CARDIAQUES ET TOUT CE QUE VOUS AVEZ OUBLIE !Modérateurs :





Frédéric Sacher - CHU de Bordeaux, FRA




Daniel Gras - Nantes, FRA

Samedi 16 juin / 11:00 - 12:30LA CONSULTATION EN LIVE : DEMARCHE DIAGNOSTIQUE ET THERAPEUTIQUE CHEZ LE PATIENT STIMULE ET SYMPTOMATIQUE (DOULEUR THORACIQUE, DYSPNEE, PALPITATIONS, MALAISE, SYNCOPE)Modérateurs :








Daniel Gras - Nantes, FRA

www.cardiostim.com


Cardiostim 2012

PartnersPress partners

Societies partners

www.congenitalcardiologytoday.com

www.neonatologytoday.net

www.elsevier.com

www.ipej.org

www.oxfordjournals.org

www.ihe-online.com

www.cardiacrhythmnews.com

www.theheart.org

Croatia Society of Cardiology www.kardio.cr

Danish Society of Cardiology www.cardio.dk

www.crc.springer.de

German Cardiac Society www.dgk.com

Polish Cardiac Society www.ptkardio.pl

Portuguese Society of Cardiology www.spc.pt/spc/

Society of Cardiology of the Russian Federation

www.cardiosite.ru

www.karger.ch

www.onlinelibrary.wiley.com

www.hospimedica.com

www.touchcardiology.com

www.cardiologyjournal.org

62

Advance program

General Information

www.cardiostim.com

Scientific OrganizatiOn

ChairmanDr Philippe Ritter

Scientific CoordinatorJocelyne ToulousePhone: +33 (0)1 47 56 24 56Fax: +33 (0)1 47 56 24 [email protected]

generaL OrganizatiOn

Managing Director Michel FilziPhone: +33 (0)1 47 56 52 [email protected]

SalesMonique Gauthier Phone: +33 (0)1 47 56 21 18Fax.: +33 (0)1 47 56 24 [email protected]

Director Healthcare Division Laurence Gaborieau Phone: +33 (0)1 47 56 21 [email protected]

Marketing & CommunicationAurore BlitzPhone: +33 (0)1 47 56 50 [email protected]

Marie Le Quellec - KernPhone: +33 (0)1 47 56 50 [email protected]

regiStratiOn

Congress RegistrationNathalie MontesPhone: +33 (0)1 47 56 24 83cdmregistration@ reedexpo.fr

1) CARDIOSTIM 2012 AND ITS TECHNICAL EXHIBITION WILL BE HELD AT NICE ACROPOLIS CONVENTION CENTER 1, Esplanade Kennedy - 06302 Nice Cedex 4 - France

2) LECTURES, POSTERS AND VIDEO-CLIPS Check our website www.cardiostim.com

Oral presentationsAcceptance: the oral presentations will consist of invited and submitted papers. The Scientific Committee will select papers for presentation from the submitted abstracts. All accepted abstracts will be published in a special issue of an international journal.

Posters sessionsAll posters must be submitted in form of abstracts. A number of posters will be selected by the Scientific Committee for presentation at posters workshops. CAUTION: Portrait display (taller than wide) for all posters, i.e. height 54” in x width 36” in (1,40 m x 0,90 m).

Video presentationsThe presentation must be purely scientific without advertising. Total length of presentation: 15 minutes at the maximum. Special viewing room for videotape presentations will be available. Accepted standards are: NTSC, Pal and Secam VHS 1/2 sizes, DVD, VCD.

3) OFFICIAL LANGUAGEEnglish.

4) TECHNICAL EXHIBITSThe technical exhibits will be located adjacent to the Conference rooms.

5) LUNCHEON TICKETSLuncheon tickets are strictly reserved for Cardiostim registrants. Registration is possible on our web site: www.cardiostim.com. Price per ticket. Lunch will be served in le Bistrot des Muses located in the Convention Center, Level 3. Check our website www.cardiostim.com

6) HOUSING• Reservation exclusively through Mathez Travel:

www.cardiostimhousing.comBenefit from negotiated rates. The congress is holding a large contingent of rooms in Nice, but rooms will be assigned on a first-come, first-served basis.

7) TRANSPORTATION

- by train Book your travel on: www.voyages-sncf.com

- by air • Many international airlines serve the Nice international airport (www.nice.aeroport.fr).Air Fares discountsEven ID: 12138AFValid from June 8 2012 to June 21, 2012Even location: Nice, FranceDiscounts are applied to a wide range of airfares on all Air France and KLM flights worldwide, if passengers are travelling on the following classes of travel: Espace Affaires (Business) and Economique (Coach).10% rebate is applied on published non-restrictive public fares.A reduction of 5% is granted on restrictive-discounted fares. Use the website of this event or visit to: www.airfranceklm-globalmeetings.comKeep the document to justify the special fares with you as you may be asked for it at any point of your journey.To locate your nearest Air France and KLM sales point, visit: www.airfrance.comYou will need to quote the reference given above which is registered in Air France and KLM data under: GGAIRAFEVENTNEGOFrequent flyer/loyalty programs of Air France and KLM partner airlines are credited with «miles» when Air France or KLM flights are used.

• During the congress, a free shuttle service to the Congress Center will be available to registrants staying in Nice at Cardiostim hotels. Information on www.cardiostim.com

Lumax 740 with ProMRI®

NEW Lumax 740 ICD series with ProMRI®

BIOTRONIK’s breakthrough innovation delivers the world’s fi rst ICD series providing patients access to MRI.

Solutions for today – innovations for tomorrow

www.biotronik.com / promri

World’s fi rst ICD series approved for MRI

cardiostim 2012 advance program

Documents